Magnetic Resonance Imaging (MRI) is frequently used for soft tissue since it can easily detect small tumours that might be harder to see with a CT scan or X-ray. CT scans and X-rays, on the other hand, are better for bone and lung structures. 

MRI technology is also advancing using AI, which assists medical doctors with image reconstruction, workflow efficiency, and automated measurements.

We’ve researched the latest trends and statistics to help you understand how they help detect cancer.  

Latest MRI Statistics

• The market is projected to hit USD 11.69 billion by 2032, growing at a CAGR (Compound Annual Growth Rate) of 5.1% from 2024 to 2032.¹
• High-strength units and the availability of open MRI for claustrophobic patients drive this market.¹
• Due to its more accurate nature, the market for closed MRI systems dominates.¹
• Brain and neurological MRIs account for the largest share of revenues.¹
• By region, Asia-Pacific dominates (45.8% share and fastest-growing region) due to the rising patient population and growing uptake of innovative diagnostics.¹
• Americans hold the largest market on account of a prevalence of chronic diseases that reaches over 29% globally.¹

The Future of the MRI Industry

U.S. has the largest market share in the MRI industry as a result of extreme numbers of chronic diseases found globally, accounting for more than 29% of the burden.

Cancer, cardiovascular disease, or neurological disorders are only some examples of slowly progressing or long-lasting diseases that pose challenges to the healthcare system by accumulating millions of people each year who require additional MRI scans for diagnosis, monitoring, and treatment planning. 

The high prevalence of these diseases in Americans, along with a well-developed healthcare system and access to modern technology, results in a demand for MRI equipment and services, thus accounting for the largest market share.

Cancer Statistics in Switzerland: More New Cases, Fewer Cancer Deaths

Learn about cancer statistics in Switzerland: increasing cases but declining mortality, leading to better survival outcomes.

Aeon BlogCarolin Kaulfersch

Open and closed MRI systems are also a new trend to watch out for. Chronic illnesses regularly involve intricate, broad imaging to empower accurate analysis and long-term monitoring, which is why such complex MRI technology is necessary.

High-strength MRI machines offer more detail and provide a better-quality image to aid in the recognition and treatment of complicated conditions such as cancer or nervous disorders. 

A further benefit of open MRI machines is that they allow for a more relaxed experience when imaging claustrophobic patients while maintaining quality. MRI is an incredibly important component of a care platform for chronic diseases.

It also illustrates how vital it is that MRI provides clinicians with what they need to deliver the best possible healthcare results in all areas.

Breast Cancer Detection Statistics

• American Cancer Society (ACS) recommends that all women at age 40 should have screening for breast cancer every year.⁶
• 22 cancers per 1000 screens mean ten times the rate of mammography in average-risk women and twice as high in high-risk women.⁶
• Increased demand for breast MRIs and shortage of radiologists have resulted in an extended waiting period, delaying diagnosis.⁶
• Machine learning can increase the sensitivity of MRI interpretations for breast cancer detection, reduce false positives/negatives, and help radiologists detect breast cancer.⁶

A Breast Cancer Detection Study

Bio Med Central conducted a breast cancer detection study to understand how MRIs work. The study evaluated the ability of MRI to identify any residual cancer in breast cancer patients who may have undergone neoadjuvant chemotherapy (NAC) and questioned the influence of clinical and pathological parameters on MRI in terms of evaluating the size of the residual tumor.

The study involved 91 patients with breast cancer (92 tumors in total) who underwent NAC. Pre- and post-treatment MRI scans were conducted. MRI and histological examination controlled patients’ outcomes. 

For 89 tumors, the post-treatment tumor volume, according to MRI, was more significant than the actual tumor size, according to pathology data obtained during treatment. The researchers also examined other clinicopathological variables to determine which impacted the measurement disparity observed between MRI and pathology.

MRI demonstrated an accuracy of 76.09% in detecting invasive residual disease with a sensitivity of 75%, specificity of 78.57%, positive predictive value of 88.89%, and negative predictive value of 57.89%.

The tumor size estimated by MRI was driven with the sizes analyzed by pathology. The MRI was more accurate in measuring residual tumor size for the tumor that is < 5 cm on the initial MRI, high grade, and HER2-negative breast cancer.

The study established that MRI is usually accurate in predicting tumor response to NAC based on its size, grade, and hormonal receptor status at the start of the treatment.

MRI Statistics By Country

• In MRI density, Japan has 57 units per million people, trailed by Korea at 36 and the United States at 28. ³
• In contrast, Mexico and Colombia have much lower densities; Mexico's is 3 per million, while Colombia's is 0.2 per million. ³
• MRI scan costs can range from $500 to $4,000, depending on the region, the service and the healthcare provider.³
• The U.S. performs about 40 million scans annually. ³
• In 2017, Hitachi was responsible for 3% of the global diagnostic imaging market, which is anticipated to decrease to 2.7% by 2024. ³
• The market is ruled by Siemens Healthineers, General Electric Healthcare, and Philips, which are all expected to hold market shares of about 20%. ³
• The $40 billion global diagnostic imaging market is driven by the significant need to detect chronic health conditions primarily affecting aging populations. ²

The Rise in the MRI Industry

The $40 billion worldwide diagnostic imaging market is growing due to the enhanced necessity of detecting chronic health conditions, primarily in the aging population. An increased lifespan is connected to people becoming ever more sensitive to health issues such as cancer, heart troubles, and disorders related to the nervous system. 

The ability to detect these disorders in early stages through diagnostic imaging methods, including MRI and CT scans, is crucial for managing these problems. 

The demand for high-end imaging technology is accelerating market growth as healthcare systems reinforce the importance of preventive care and quick diagnosis for enhanced patient outcomes.

Hitachi’s Advancements

According to Hitachi’s creators, with two asymmetric pillars, Hitachi's open-platform OASIS™ MRI is unique among its peers. It provides a large and clear panoramic view for patients, which is a huge advantage for those who suffer from claustrophobia or general anxiety and a better experience for most people.

The first open MRI in the MENA region with a 1.2 Tesla magnet was installed recently at Saint Joseph Medical Center in Beirut, Lebanon. The proper installation comes with significant improvements to the center, all of which have occurred since its installation.

Scanning times have been cut from 40 minutes on older systems to just 15 – 18 minutes for musculoskeletal scans with OASIS™. The efficiency has increased patient volume in the center from 12 patients per day to 25, which has complemented the health system's business.

Whole-Body Magnetic Resonance Imaging (WB-MRI) Statistics

• WB-MRI can identify tumors in areas not included in existing programs, with up to 10% diagnosis rates. ⁴
• In 12 analyses involving 5,809 subjects, the cancer detection rate was 2.0%, and 1.5% of 3,287 participants were diagnosed with confirmed malignancies.⁴
• Asymptomatic research participants showed a detection rate for cancer ranging from 0% to 10%.⁴
• Research from 2014 regarding 1,102 cancer patients found that WB-MRI is sensitive at 0.94 in identifying bone metastases.⁴
• An analysis involving 2,500 people showed that WB-MRI detected possible problems in 2.5% of situations, with confirmed malignant tumors using histology.⁴

The success of whole-body MRI (WB-MRI) in detecting tumors is frequently outside the reach of established cancer screening programs. 

According to research studies that use WB-MRI, the diagnosis rate for cancer may rise to 10%, which makes it an essential technique for spotting malignant tumors in organs that are often overlooked by standard screening procedures, like mammography or colonoscopy. 

This points out the likely powers of WB-MRI to spot cancers sooner and in areas that are customarily missed in other examinations.

Asymptomatic volunteers' WB-MRI screening rates for cancer can vary greatly, ranging from 0% to 10%. The variance is probably due to variations in study size, imaging techniques, and the populations studied.

The results point to the potential of WB-MRI in helping detect cancer in people with no overt symptoms; nonetheless, results can vary greatly due to the variance in study criteria and sample size, making further study essential to pinpoint its standard usage.

The WB-MRI Study

The objective of the Hercules research study, driven by Prenuvo, is to show the success of whole-body MRI (WB-MRI) in identifying early-stage diseases when patients are asymptomatic.

Over ten years, this study will gather data on its diagnostic reliability, which might redefine healthcare by moving from reactive to proactive care. Through its advanced imaging technology, Prenuvo’s WB-MRI generates over a billion data points and is meant to detect health problems all over the body.

With backing from prominent investors, the study aims to prove WB-MRI to be critical in personalized medicine and early disease detection.

“The Hercules clinical research study will utilize Prenuvo’s brand of whole-body MRI based on years of clinical practice to demonstrate the potential of this technology in becoming a cornerstone of early disease detection and personalized medicine, further validating and paving the way for a more proactive approach to healthcare.”

MRI Cancer Detection Trends

• Emerging MRI technologies, including AI integration and helium-less systems, are sometimes reducing exam times, though the exact reduction depends on the system and procedure.⁵
• The market analysis reveals that the MRI market is expected to grow rapidly, with increased demand at 47% annually. ⁵
• 5T remains the largest segment in the MRI systems market, and 3T systems are widely used.⁵
• Using Helium-Free MRI Systems.⁵
• United Imaging occupies 8% of the Asian market, far behind all-embracing market players such as Siemens, General Electric, Philips, and Canon.⁵
• Artificial intelligence improves MRI technology in MRI systems and the accompanying post-processing software. ⁵

The Future Trends of MRIs

AI’s advanced reconstruction methods can notably boost the quality of images. This technology's patient positioning features and automation of duties specialized for medical subspecialties, specifically cardiology, neurology, and orthopedics, support workflow enhancement. 

AI aids healthcare personnel in accelerating their workflows and automating metrics, therefore yielding more accurate results and contributing to streamlined diagnoses and treatments.

MRI systems without helium are relatively new advancements in the medical imaging industry. These MRI machines use liquid helium to cool the superconducting magnets, although helium is expensive and has become rare. Helium-free systems make it possible to do away with using helium, thereby cutting costs and improving efficiency. 

They employed sophisticated cooling technologies that do not need constant maintenance and constant refilling with helium; hence, they are environmentally friendly, which can also help reduce the time the machines could take off, thus improving the delivery of health care services to the patients.

Due to their widespread availability and cost-effectiveness for many clinical needs, 1.5T (Tesla) machines dominate the MRI systems industry. 3T systems provide superior resolution and are commonly seen in neurological and musculoskeletal applications. 

While 7T MRI systems are extremely powerful and can yield impressively detailed images, they are mainly used for research because of their higher cost and complexity.

Moving Forward

MRIs will likely maintain their essential function in cancer detection, offer significant insights into early diagnosis, and inform treatment strategies. The more advanced AI and other technologies are utilized, the more significant the improvement in MRI scans' sharpness and efficiency will be.

Also, the technology of MRI systems that do not require helium has been supporting reductions in operational expenses and ecological impact, improving the accessibility of MRI technology in health facilities globally. 

This new direction highlights the effort for more environmentally friendly initiatives while sustaining top-quality diagnostic imaging. 

In the upcoming years, utilizing AI and cutting-edge technology within MRI systems will likely contribute to the advancement of cancer detection. These advances will probably shorten diagnostic timelines and boost precision, helping clinicians focus on more complicated problems. 

As MRI technologies develop, they will become increasingly vital in early cancer detection and customized treatment, thus improving the chances of survival. At Aeon, we provide full body scans that can help with early detection of major illnesses. 

Book a scan with us today and take a step towards a healthier you. 

Frequently Asked Questions

Sources

1. Statista
2. Top Global Companies by Diagnostic Imaging Market Share
3. Market Research Future - MRI Systems Market Report
4. NCBI - MRI and Cancer Detection
5. Health Imaging - Top MRI Trends
6. Breast Cancer Research - MRI Study

How would you feel about AI predicting whether you’re susceptible to cancer in the future?

At MIT and Mass General Cancer Center, a team tested an AI tool named Sybil to see if it could detect cancer early to help doctors treat the illness earlier. Sybil looked at a CT scan and, based on the analysis, told whether or not the patient was likely to suffer from lung cancer in six years.

New trends for detecting cancer are being developed, and AI is one of them. Although these AI-assisted cancer diagnostics are currently being used to complement traditional methods, they are not yet a standard practice.

In this article, we’ve researched the top cancer statistics you should know and added advice from medical doctors to better understand what these statistics mean for the future. 

Latest Cancer Survival Statistics

• By 2040, the number of new cancer cases per year is estimated to increase to 29. ⁴ 
• In 2040, the number of deaths due to cancer will increase to 15. 3 million. ⁴ 
• A third of human beings are diagnosed with cancer, and men have an 11% risk of cancer death and women 8%. ⁷ 
• In 2024, 14,910 children and adolescents ages 0 to 19 will be diagnosed with cancer, and 1,590 will die of the illness.
• The four most common cancers in the world include female breast, lung, bowel, and prostate cancers. ⁹

Why Cancer Prevalence Rates Are Increasing 

It is estimated that the annual cancer incidence will rise to 29 by 2040. 9 million, with 15. 3 million deaths globally. Some reasons could be population, an aging society, or lifestyle. 

Today, cancer will kill about one in four people, and roughly one-third of the world's population will get cancer over their lifetimes.

The majority (61%) of the 76 countries included in a World Health Organization survey now have primary cancer care identified as part of their universal health benefits packages (HBP).

However, this still leaves most of the world's population without access to effective cancer treatment. In addition, only 28 countries of the participating states provide palliative care (relieving symptoms in patients, especially pain in terminally ill patients), so there is a big gap in support for terminal patients.

The most common breast, lung, colon, rectal, and prostate cancer accounts for more than 40% of all cancers worldwide.

Colorectal Cancer Screening: What You Need to Know for Early Detection

Colorectal cancer: third most common cancer. Early detection and screening improve survival. Learn prevention methods.

Aeon BlogCarolin Kaulfersch

These numbers indicate the importance of the work to prevent, detect, and treat this deadly disease. These are the voids that will need to be filled if we are going to turn back the tide of rising cancer incidence and mortality rates collectively.

Cancer Survival Stats of the US

• The population of cancer survivors in the United States should surpass 26 million within the next two decades.¹
• The number of people expected to survive five years or more after a cancer diagnosis will increase by about 53% by 2040, compared to 2022..¹
• Today, over 3/4 of all cancer survivors are over 60 years of age in the United States.¹
• Americans diagnosed with newly diagnosed metastatic cancers is expected to increase to 693,452 in 2025.¹
• Breast cancer survivors currently account for an estimated 22% of all survivors, 4% of women in the United States, with approximately 4 million people.¹
• The total figure of patients surviving prostate cancer is 10 percent or approximately 1.725 million, and the number of patients who constitute 20 percent of the total is approximately 3.5 million.¹
• Of all cancer survivors in the United States, approximately 8% are melanoma survivors, with 1.5 million people constituting the group.¹
• The corresponding numbers for colorectal cancer are 1.4 million people, and of those, 8% are cancer survivors.¹
• The cumulative lifetime risks of developing any invasive cancer is 40.9% for men and 39.1% for women.¹
• Cancer deaths in the U.S. are down 33% since 1991 – a combination of research, better treatment, and earlier diagnosis – but due to smoking rates as well.¹
• All targeted delivery methods of antismoking programs have been successful, reducing lung cancer mortality from 90/1000 in 1990 to 38/1000 for men and from 6 /1000 in 2002 to 4 /1000 for women.¹

The Effectiveness of Anti-Smoking Campaigns

A study of interest on the impact and cost-utility outcomes of the FDA's nationally televised anti-smoking public health campaign, The Real Cost, intended to prevent cigarette smoking among US youth by the American Journal of Preventive Medicine (AJPM.)

The campaign, which launched in February 2014, targets youths aged 12 to 17 years who have never smoked but are flirting with the habit, as well as those who already have tried smoking. 

Heavily promoted across TV, radio, online, and other DOC channels with messaging that revolves around the theme “Every cigarette costs you something.”

The campaign addressed the cosmetic side effects of smoking, addiction, and cigarette ingredients. The campaign had met the more specific objective of ad awareness amongst over 90% of the target consumers during the first three years. This subsequently led to an increase in the proportion agreeing with tobacco harm beliefs by 11.5% 14 months after implementation of the policy as compared to prior.

Research from 2017 showed that, among young people who perceived they saw a lot of the campaign, there was a 30% lower risk of starting to smoke. The campaign was estimated to prevent 348,398 U.S. youth from smoking. 

To evaluate the cost-effectiveness of this model, the study employed two primary metrics: cost per QALY saved and ROI. This is in line with other health interventions of 1 QALY (e.g. gaining ~5 years.) The campaign will be more cost effective if we assume that getting one less smoker to smoke results in lives saved for $24,000 each by eliminating smoking in a non-discounted way.

In contrast, the ROI analysis produced a dollar estimate of what would have been spent to deliver healthcare related to smoking without the campaign expenditure. Each cost-effectiveness analysis determined "The Real Cost" to provide significant public health benefits at a reasonable economic cost.

And that demonstrates the importance of anti-smoking campaigns, some of which obviously are quite successful in convincing people not to smoke.

Cancer Survival Stats of the UK

• The death rate of cancer in the UK has improved significantly over the past 50 years. ²
• Data obtained from January 2023 shows new cancer cases at 19,169, of which only 38% were classified as stage I or II when diagnosed. ²
• The proportion of cancers diagnosed in January 2023, where the stage was unknown, is increasing.² 
• The NHS Long Term Plan is to ensure three-quarters of cancers are detected at stage 1 or 2 by 2028.²
• The quicker diagnosis criteria were met for 77 families by March 2024.²
• A total of 33% of patients were diagnosed with cancer or had cancer excluded within 28 days from referral.²

The NHS’s Future Plan for Cancer Diagnoses 

By 2028, the NHS Long Term Plan hopes to diagnose three out of four cancers at stage 1 or 2. One of the top priorities is early cancer detection, and this document aims to help achieve this.

Another significant step the NHS took regarding the cancer battle was adopting the faster diagnosis standard in March 2024. Under this standard, at least 75% of patients receiving an urgent GP referral or screening should have a cancer diagnosis or exclusion made in 28 days. 

Early cancer detection remains a problem that affects different social classes. Alamgir, H. Mahmood, and B. Azad reported a temporal decline in early diagnosis, indicating that new diagnosis rates from March to May 2020 were 52% for the least deprived areas, down from 58%.

It was noted that those living in the most deprived areas are worse affected by the diagnosis in the early stage, reducing from 53% to 41%. 

Being two and five years behind the NHS target of 75% of early diagnosis by 2028, respectively, while the very deprived still lagged at 47%, it indicates the need for more efforts towards closing the gaps and enhancing the success rates of early diagnosis across all the provided groups for cancer patients.

1 & 5 Year Cancer Survival Rate Statistics

• The 5-year survival rate for breast cancer is over 80%.³
• For lung cancer, the 5-year survival rate is less than 20%.³
• Between 2013 and 2019, about 22% of liver cancer patients in the United States survived for at least five years after their diagnosis. This figure reflects the 5-year relative survival rates for various cancer types in the U.S. during that period.³

What is a 1-year and 5-year survival rate?

The 5-year survival rate for any one type of cancer is the percentage of patients who are still alive five years after diagnosis. It differs depending upon the tumour type, stage of the disease at diagnosis, and country.

Concerning breast cancer, a survival rate above 80% means that more than 80% of patients have lived for at least five years since diagnosis. Generally speaking, the survival rate for breast cancer is higher, especially for early-stage diagnosis. Whereas in lung cancer, less than a 20% 5-year survival rate equates to less than 20% of patients living for five years. This generally points to the fact that lung cancers tend to be diagnosed in later stages and, therefore, have a generally poor survival rate.

In the United States, from 2013 to 2019, the five-year survival rate of liver cancer was 22%, which indicates that roughly 22% of the patients with liver cancer survived five years or more since diagnosis. Like lung cancer, liver cancer often also presents higher mortality rates because of its potential for being diagnosed at a later stage.

These may be radically lower in developing countries because the healthcare system can be under-resourced, leading to poor diagnostics and less effective treatment. Rates can be highly dependent on cancer type and the stage at which the diagnosis is made. Generally speaking, early-stage cancers have better survival rates than later-stage ones.

The Ultimate Guide to Mammography: What to Expect and When to Get Screened

Mammography: X-ray examination for early detection of breast cancer. Learn all about the mammography procedure, screening programs, pros and cons, and available alternatives.

Aeon BlogDr. med. Felix Harder

Cancer Survival Statistics of Men and Women 

• The death rate from cancer for men is 173. 2 cases per 100,000 against 126. 4 among women.⁴
• The lowest cancer mortality rate per 100,000 in race/ethnicity and sex is 82.6 among non-Hispanic Asian/PI women, and the highest is 208. Three among non-Hispanic black men. ⁴
• Cancer patients are on the rise; despite this, there are one million cancer survivors in the United States alone. The ACS said the total number of cancer survivors will climb to 22. 5 million by 2032.⁴
• The number of actual cancer cases in children age 19 and younger has been estimated at 14,910 in the year 2024, while the cancer deaths in the group are expected to be 1,590. ⁴
• Out of pocket, Americans spent $208 on cancer this year, as estimated by Getty. ⁹ billion.  
• It has been observed that the cancer rate increases with the life expectancy, Education level, and the standard of living of individuals. ⁴

The Financial Burden Due to Cancer

It is believed that because of the growing population of elderly people, the increasing incidence of cancer, as well as the usage of new but expensive treatments, this expenditure will rise. 

A recent study by medical experts discusses the financial toxicity that patients suffering from cancer in the U.S. face. The present review notes that about half of the cancer patients experience financial impacts of their diseases and treatment: 49%, according to the study. 

Components that are believed to be on the opposite side of the scale include no health insurance, low income, no job, and early age at the disease. Such burdens result in poorer health status, indicated by lower HRQoL and increased non-adherence to cancer medication.

The authors also discovered that increasing costs during the initial stages of cancer care did not vary in different cancer types.

Consequently, while financial costs were associated with less-than-optimal compliance and poor quality of life, increased mortality rates were reported only in one study investigating financial stress.

These financial losses should also call for more robust interventions than those that seek to address the problem. 

To this end, the authors encourage the advancement of studies to design interventions that healthcare professionals may use to assist in the financial burdens experienced by malignant neoplasm patients.

Cancer Treatment Trends

• Personalised Cancer Vaccines: Different vaccines are being tested in the UK to help activate the immune response likely to attack specific cancer cells to avoid reoccurrence. Through mRNA technology, these vaccines are expected to have fewer side effects than chemotherapy and could be one of the most significant advancements in cancer care. ⁸
• Test to Identify 18 Early-Stage Cancers: A blood test invented in the U. S provides early-stage cancer indications by evaluating proteins and is cheaper than regular tests. This test could potentially change multi-cancer screening if it were to be developed further while it is still in its early stages. ⁸
• Seven-Minute Cancer Treatment Jab: For the first time, the English NHS has launched a seven-minute injection treatment for cancer instead of the intravenous process. This treatment, which targets lung and breast cancer, among others, will reduce the time spent by both patients and carers. ⁸
• Precision Oncology: Precision medicine is about accurately knowing tumors' genetic and molecular profiles to treat cancer successfully. This method's treatments have fewer side effects than traditional treatments because they are target-oriented and involve activating one or a few genes. ⁸
• Artificial Intelligence (AI) in Cancer Care: Of special concern is using AI in cancer solutions, including risk profiling, image analysis, early detection, and treatment recommendations. Advanced computer programs are catching cancer earlier and developing smart treatment plans, especially where specialists are scarce.⁸

Seven-Minute Cancer Treatment Jab

The NHS in England is set to launch a seven-minute anti-cancer injection as part of its health scheme for Atezolizumab (Tecentriq®). This immunotherapy drug has historically required intravenous administration. 

The fast injection approved by the MHRA will save hundreds of patients yearly from taking 30 to 60 minutes for treatment instead of seven minutes. Atezolizumab enhances the body’s ability to fight cancer, including lung, breast, and liver cancer.

This inventiveness is said to improve the patient's perception while at the same time relieving pressure from the stretched NH facilities without incurring any further expense.

Professor Peter Johnson, National Director of Cancer, NHS, said, “Maintaining the best possible quality of life for cancer patients is vital, so the introduction of faster under-the-skin injections will make an important difference.”

“However, we must strive to optimize the use of screening strategies, strongly encourage HPV vaccination, and continue to explore molecular markers. These markers may predict an increased lifetime risk of a particular cancer type and may justify additional or more intense screening.”

Moving Forward

These statistics show that there have been a number of innovative advancements in cancer treatment and diagnosis. Technology such as artificial intelligence will assist in developing patient-specific treatments, which will increase patient survival. 

Additionally, information concerning genetic endowments or the environment will lead to decision-making on individual cancer risks, allowing health care to be tailored more outstandingly to each patient and offering patients the treatment necessary for the specific instance of cancer. 

Last but not least, the process of individual progression, taking into account the efforts to increase the availability of healthcare for people all over the world, helps to build an understanding of the potential changes in cancer rates in the future.

However, as cancer becomes one of the leading causes of death today, it still needs more probing, funding, and technological advancement. 

If you’re interested in preventative measures and want a full body checkup, you can book a scan with our team. 

Cancer Statistics in Switzerland: More New Cases, Fewer Cancer Deaths

Learn about cancer statistics in Switzerland: increasing cases but declining mortality, leading to better survival outcomes.

Aeon BlogCarolin Kaulfersch

Frequently Asked Questions

Sources

1. Cancer Control Statistics
2. Cancer Survival Rates - Nuffield Trust
3. Cancer Survival Statistics - WCRF
4. Cancer Statistics - National Cancer Institute
5. Cancer Survival Rates Are Improving - Cancer Treatment Centers of America
6. ACS Journal: Cancer Statistics
7. 2022 Cancer Treatment and Survivorship Facts & Figures - American Cancer Society
8. Global Cancer Burden Growing - WHO
9. Worldwide Cancer Statistics - Cancer Research UK

Did you know that obesity causes 4.5 million deaths each year?¹⁴ 

Professor Julia Goedecke, a senior specialist for the Medical Research Council of South Africa, says, "People don’t understand; they see it as more of an aesthetic problem than a health problem.”

But what exactly causes obesity? Is it simply over-indulging, or what are the main contributing factors?

Senior scientist at the University of Alabama at Birmingham Nutrition Obesity Research Center, Dr. W. Timothy Garvey, M.D., explains, “The various causes of obesity are complex, involving genetics, societal, and environmental factors. Like many chronic diseases, obesity is [caused by] an intersection between genes and environment. The environment is likely to contribute more to obesity today than it did a century ago.”

Dr Caren Mangarelli, M.D., an assistant professor of pediatrics at Northwestern University Feinberg School of Medicine, agrees.

Obesity is a growing issue, and it’s not slowing down any time soon. We’ve put together a list of the latest statistics on obesity to provide more insights.

Global Obesity Statistics 

Obesity is typically defined by BMI, but it’s not a reliable measure for visceral fat, which is the more dangerous fat linked to serious health risks.

Obesity is a pressing global health issue, impacting not only wealthy countries but also low- and middle-income nations.

The authors of the Atlas, Professor Louise Baur of the University of Sydney and CEO of The World Obesity Federation Johanna Ralston, say, “Obesity is global, affecting rich and poor at ever younger ages.”

• In 2022, the prevalence of obesity varied by region, ranging from 31% in South-East Asia and African Regions to 67% in North and South America.⁵

Being overweight was mainly a problem in high-income countries but is becoming more common in low- and middle-income countries.

• In Africa, the number of overweight children under five has risen by almost 23% since 2000.⁵
• In 2016, over a third of adults in the United States were obese.⁶

A study in The Obesity Society by Allison, D.B. et al. found, “The prevalence of obesity has increased substantially in the past half-century, both within the United States and globally. This increase has occurred in virtually every age, race, and sex group. A current estimate is that roughly one-third of US adults (more than 50 million persons) are obese.”

Authors Chrysoula Boutari and Christos S. Mantzoros, on the study of obesity in Elsevier explained why this is the case, “Although overweight and obesity are considered a high-income country problem, they both are currently on the rise in low- and middle-income countries due to the global free trade, the economic growth and the urbanization these countries are experiencing.”

• In 2016, about 40% of adults worldwide were estimated to be overweight or obese.⁶
• From 2017 to March 2020, 41.9% of U.S. adults were obese, and 9.2% had severe obesity (having a BMI of 40 or higher).^7,9
• In the U.S., 58% of adults with obesity have high blood pressure, which is a risk factor for heart disease. Additionally, about 23% of adults with obesity have diabetes^.7
• In the U.S. during 2017-2018, obesity was most common among adults aged 40-59 (11.5%), followed by those aged 20-39 (9.1%), and then adults 60 and older (5.8%).⁹
• By 2035, obesity in the African region is expected to have an annual economic impact exceeding $50 billion, equivalent to 1.6% of the region's gross domestic product (GDP).¹⁰
• Obesity rates in North and South America are expected to increase for both men and women over the next 11 years, with nearly half of all adults (47% to 49%) likely to be affected by obesity by 2035^.10
• In the Western Pacific region, obesity among adults is projected to double, increasing from 8% to 19% for men and from 9% to 16% for women.¹⁰
• In 2020, about 42% of the world's population aged 20 and older were estimated to be overweight or obese. By 2035, this is expected to increase to 46%.¹²
• On the South Pacific island of Tonga, 87% of women and 80% of men are overweight or obese.¹²
• About 33% of men and women in the United States report being obese. While in South Korea, this proportion is 3.2% for women and 5.3% for men, in Germany, this figure is 19% for both sexes.¹²
• North and South America had the largest proportion of obese men in 2020. But by 2035, the Western Pacific is anticipated to lead, with over 41% of males aged 5 to 19 obese.¹²

Dealing with this problem requires environmental and social level adjustments as it is complicated. Those who are obese can improve their health by working with a health coach to adopt better eating, exercise and lifestyle choices. Additionally, they should consult a healthcare practitioner about prescription drugs.

Obesity Death Rate Statistics

The link between obesity and poor health outcomes, including all-cause mortality, is well-known. Globally, over 2.8 million people die annually due to being overweight or obese. Additionally, an estimated 35.8 million Disability-Adjusted Life Years (DALYs), representing 2.3% of the global total, are attributed to being overweight or obese.¹⁵ It's also important to consider the various health risks associated with obesity and being overweight.

Dr. Samuel Klein, director of the Center for Human Nutrition at Washington University School of Medicine in St. Louis, emphasizes a crucial point about being overweight: “Being overweight doesn’t increase your risk of dying. It increases your risk of diabetes [and other conditions].”

Supporting Dr. Klein’s view, Dr. Steven Heymsfield, executive director of the Pennington Biomedical Research Center in Louisiana, adds:

Both experts highlight the importance of focusing on specific health markers rather than weight alone. This perspective is particularly significant in light of recent statistics.

• In 2019, an estimated 5 million deaths from noncommunicable diseases (NCDs) like heart disease, diabetes, cancer, neurological disorders, chronic respiratory diseases, and digestive disorders were linked to higher-than-optimal BMI.^5,11
• In the same year, being overweight or obese caused over 15% of deaths in several middle-income countries in Eastern Europe, Central Asia, North Africa, and Latin America.⁶

• Obesity claimed 8–10% of deaths in the most affluent countries in 2019. In other middle-income countries, this ratio practically doubled. ⁶
• In many low-income countries, especially in Sub-Saharan Africa (SSA), obesity accounts for less than 5% of deaths due to prevalent malnutrition.⁶ In 2019, 32.7% of children under five in SSA were stunted.¹⁶ Additionally, SSA faces a double burden of malnutrition, with both undernutrition and overweight/obesity, and sometimes a triple burden, including anemia in women of reproductive age.
• The average age-adjusted death rate in the United States sharply changed from 5.99 (95% confidence interval (CI), 5.89–6.1) in 1999 to 14.49 (95% CI, 14.35–14.64). The ICD-10 codes in the death records from 1999 to 2016 refer to illnesses associated with obesity or being overweight as responsible for this 141.90% rise in mortality rate.¹³
• For white people in the U.S., age-adjusted obesity mortality rates increased significantly from 5.61 (95% CI, 5.5–5.72) in 1999 to 14.1 (95% CI, 13.94–14.26) in 2016, a rise of 151.34%. ¹³
• Between 1999 and 2016, the American Indian or Alaska Native group saw the highest 17-year change in age-adjusted mortality rate, 230.04%, for deaths with an ICD-10 overweight and obesity code on the death certificate. ¹³
• When overweight and obesity were considered significant factors, the age-adjusted mortality rate increased by 173.19% for males and 116.89% for females from 1999 to 2016. ¹³
• Between 1999 and 2016, white males experienced a significant 176.03% increase in mortality rates due to overweight and obesity. For white females, the increase was lower at 129.36%, but the gap between the genders is widening. ¹³
• Overweight and obesity increased the mortality rate for black or African-American females by 72.83% from 1999 to 2016. However, the dramatic 165.34% increase in age-adjusted mortality rates for black or African-American males with overweight and obesity diagnosis, according to ICD-10 codes, overshadows this rise. ¹³

Obesity, responsible for nearly 10% of deaths in 2019, is a critical global health issue. Fatality rates linked to high apoB (protein in the blood that helps transport cholesterol and fats) have surged, especially in middle-income countries and certain U.S. demographics.

Dr Heymsfield emphasizes that sustainable lifestyle changes can effectively manage weight, making drastic measures like crash diets unnecessary when apoB levels remain consistent.

Dr Ethan Lazarus, MD, a family physician and obesity medicine specialist in Greenwood Village, Colorado, alternatively suggests, "Instead of just focusing on what to eat, it's nice to back up a few steps and think about why we are eating the way that we're eating because most of our eating behavior is not predetermined by choice.”

According to experts, prioritizing long-term wellness goals through prevention techniques rather than relying on quick fixes is the way forward, which, Dr. Lazarus emphasizes is the first step to figuring out “your eating patterns, eating triggers, and why you eat in a certain way."

Obesity Statistics by Demographics

Obesity doesn’t have a typical age group where it’s most prevalent. It is a global epidemic that affects people regardless of age, gender, or race. Particular emphasis is placed on groups severely affected by obesity, especially children. Obesity in children is not a normal part of development.

However, Dr. Mangarelli explains that the reasons for the worrisome rise in childhood obesity are largely the same as those affecting adults. “Children have that added barrier that they have less control over their home environment than the adults in charge of their care,” she says.

• In 2022, about 37 million children under the age of 5 were overweight worldwide.⁵
• Among adults aged 18 and older, 2.5 billion were overweight, including over 890 million with obesity in 2022. This means 43% of adults (43% of men and 44% of women) were overweight, up from 25% in 1990.⁵
• About 16% of adults worldwide were obese in 2022, with the global prevalence of obesity more than doubling since 1990.⁵
• Nearly half of the children under five years old who were overweight or obese in 2022 lived in Asia.⁵
• The rate of overweight (including obesity) in children and adolescents aged 5–19 has significantly increased from 8% in 1990 to 20% in 2022. This increase is similar for boys and girls: in 2022, 19% of girls and 21% of boys were overweight.⁵
• In 1990, only 2% of children and adolescents aged 5-19 were obese, totaling 31 million. By 2022, this number rose to 8%, with 160 million young people affected.⁵
• In 2016, the average BMI for women worldwide was about 25, the threshold for being overweight.⁶

"Obesity among minority racial groups and individuals living in rural areas can be attributed mostly to societal and environmental factors," according to Dr. Garvey and Dr. Mangarelli. 

People who belong to Black or Hispanic communities face financial difficulties that increase their likelihood of experiencing obesity, which confirms a connection between income inequalities and health disparities.

• From 2017 to March 2020, non-Hispanic Black adults in the U.S. had the highest obesity rate at 49.9%. They were followed by Hispanic adults at 45.6%, non-Hispanic White adults at 41.4%, and non-Hispanic Asian adults at 16.1%.⁷
• Between 2017 and March 2020, the highest obesity rates among U.S. adults were found in those with a high school diploma or some college education (46.4%). This was followed by individuals with less than a high school diploma (40.1%), and those with a college degree or higher had the lowest rates (34.2%).⁷
• Between 2017 and March 2020, there were no significant age group differences in obesity rates. Obesity affected 39.8% of U.S. adults aged 20-39, 44.3% aged 40-59, and 41.5% of adults aged 60 and older.⁷
• According to the 2017–2018 National Health and Nutrition Examination Survey (NHANES), about 19.3% of U.S. children and adolescents aged 2–19 are obese, with 6.1% having severe obesity and another 16.1% overweight.⁸

• From 2017 to 2018, obesity was least common among non-Hispanic Asian adults at 17.4%, compared to 42.2% in non-Hispanic white adults, 49.6% in non-Hispanic black adults, and 44.8% in Hispanic adults.⁹
• In the same period, obesity among men was least prevalent in non-Hispanic Asians (17.5%), whereas non-Hispanic whites had a rate of 44.7%, Hispanics were at 45.7%, and non-Hispanic blacks at 41.1%. Despite these differences, obesity rates among non-Hispanic whites, blacks, and Hispanics did not vary significantly.⁹
• For women, non-Hispanic Asians again showed the lowest obesity rates in 2017-2018 at 17.2%. On the other hand, 39.8% of non-Hispanic white women, 43.7% of Hispanic women, and 56.9% of non-Hispanic black women were obese.⁹
• During this time, severe obesity affected more women (11.5%) than men (6.9%) in the U.S.⁹
• Among all groups, severe obesity was most prevalent in non-Hispanic black adults at 13.8% and least in non-Hispanic Asian adults at 2.0%.⁹

• Between 2020 and 2035, obesity rates are projected to rise from 10% to 20% among boys and from 8% to 18% among girls worldwide.¹⁰
• Obesity rates among children and adolescents in Africa are expected to rise from 5% to 14% during 2020 to 2035.¹⁰
• By 2035, the prevalence of obesity among women in the African region is expected to increase to 31%.¹⁰
• Obesity among children and teens in North and South America is expected to increase from 20% to 33% for boys between 2020 and 2035.¹⁰
• The prevalence of obesity among children and adolescents in the Eastern Mediterranean Region is expected to rise from 11% to 23% between 2020 and 2035, affecting both boys and girls.¹⁰
• By 2035, more than 40% of women in the Eastern Mediterranean Region are expected to be obese.¹⁰

• Between 2020 and 2035, obesity among children and adolescents in Europe is expected to increase, with 14% of girls and 21% of boys estimated to be obese by 2035.¹⁰
• Obesity is estimated to afflict 39% of men and 35% of women in the European region by 2035.¹⁰
• Southeast Asian children and teens are rarely obese. However, from 2020 to 2035, it is expected to rise from 3% to 11% in girls and 5% to 16% in boys.¹⁰
• From 2020 to 2035, Southeast Asian adult obesity is anticipated to rise from 4% to 10% in men and 8% to 16% in women.¹⁰
• Obesity rates for Western Pacific Region children and teens are expected to rise from 9% to 28% for girls and 19% to 41% for boys between 2020 and 2035.¹⁰
• The 2020 worldwide obesity rate was 10% for boys and 8% for girls aged 5–19. By 2035, their numbers are expected to double.¹²

Notably, boys are more likely than girls to gain weight. Low-income and minority groups should be especially concerned about this inclination, which is aggravated by things like limited access to healthy food sources and safe recreational locations. 

To prevent future health services from becoming overcrowded and affecting the economy, it's important to focus on teaching kids healthy habits, starting community service projects that help people in need, and supporting laws that ensure everyone has access to a healthy diet and a physically active lifestyle.

At the White House signing of the Healthy, Hungry - Free Kids Act in 2010, Michelle Obama said, "We can all agree that in the wealthiest nation on Earth, all children should have the basic nutrition they need to learn and grow and to pursue their dreams, because, in the end, nothing is more important than the health and well-being of our children. ... These are the basic values that we all share, regardless of race, party, religion. This is what we share. These are the values that this bill embodies."

Cost of Obesity Statistics

Christina Hansen Edwards, a researcher at the Norwegian University of Science and Technology (NTNU), says, "We often hear that obesity represents a high cost for individuals and society because it increases the risk of health problems. All in all, however, the costs associated with being overweight are much higher.”

The obesity epidemic has major economic consequences. It's a growing global health issue with significant health and economic effects. Most of what we know about these economic impacts comes from high-income countries. If no action is taken, the global costs of overweight and obesity are expected to hit $3 trillion annually by 2030 and exceed $18 trillion by 2060.⁵

United States Senator of South Dakota Mike Rounds necessitates:

• In 2019, in the U.S., annual medical costs for adults with obesity were $1,861 higher per person compared to adults with a healthy weight.⁷
• For adults with severe obesity, the extra costs were $3,097 per person, adding up to nearly $173 billion in medical expenses in 2019.⁷

Gudrun Maria Waaler Bjørnelv, a researcher at NTNU's Department of Public Health and Nursing, considers not only the individual economic impact but also the societal impact, "Although the individual costs are highest for people who are obese, the total costs for society are highest with people who are overweight since there are many more people who are overweight than obese.”

Besides societal impacts, the severe projected costs affect individuals and the economy.

• The economic impact of obesity reduced global GDP by 2.4% in 2020 and is expected to rise to 2.9% by 2035.¹⁰ 
• Obesity had a significant economic impact in 2019, averaging 1.76% of GDP across eight countries. This ranged from 0.80% of GDP in India to 2.42% in Saudi Arabia.¹¹
• These annual impacts are comparable to the effects of COVID-19, which caused the world economy to shrink by 3% of GDP in 2020, the pandemic's worst year.¹⁰

• By 2035, the economic impact of high BMI is projected to be significant in various regions:
  1. North and South America: $1.5 trillion annually (3.7% of GDP).¹⁰
  2. Eastern Mediterranean Region: Over $160 billion annually (3% of GDP).¹⁰
  3. Europe: Over $800 billion annually (2.6% of GDP).¹⁰
  4. Southeast Asia: Over $250 billion annually (more than 2% of GDP).¹⁰
  5. Western Pacific Region: $1.5 trillion annually (3% of GDP).¹⁰
• In 2019, the per capita cost of obesity ranged from $17 in India to $940 in Australia.¹¹

• In 2019, obesity-related medical expenses made up 90% of direct healthcare costs on average in all countries.¹¹
• In the same year, informal caregivers' time constituted more than 90% of the average direct non-medical costs for obesity across all countries.¹¹
• Additionally, the costs of early deaths represented a significant portion (56%–92%) of the indirect expenses related to obesity in 2019.¹¹
• Obesity expenses in Spain are predicted to triple between 2020 and 2060, while they are predicted to grow 19 times in India. Eight nations will have an average cost of around 3.57% of GDP by 2060, with Thailand accounting for 4.88% and Spain for 2.43%.¹¹
• Overweight and obesity are predicted to have a $4.32 trillion economic impact on the world economy by 2035, up from $1.96 trillion in 2020.¹²

Obesity is creating a severe financial impact. However, there is a light at the end of the tunnel. If we calculated it correctly, for every 5% reduction in body weight, healthcare costs could decrease by 7%, emphasizing the economic benefits of effective obesity management.

Addressing this problem will be essential for maintaining economic stability and health.

If you’re proactive about your health, book a full body scan with us and receive your results directly on your phone.

Frequently asked questions

Sources 

1. Mayo Clinic
2. WebMD
3. Very Well Health
4. Clinic Barcelona
5. WHO
6. Our World in Data
7. CDC
8. CDC
9. CDC
10. World Obesity
11. BMJ Global Health
12. Statista
13. Author Manuscript
14. Unilever
15. WHO
16. Cambridge Open Access

While MS can emerge at any age bracket, diagnoses usually occur in individuals aged 20 to 40 years old.¹ 

Symptoms range from mild tingling sensations to severe mobility issues with unpredictable outcomes, creating daily challenges faced by those living with this condition. 

Incidentally, women are three times more likely than men to show signs of MS, potentially indicating hormonal influences on its development. We’ve complied a list of the latest statistics about MS, the field's developments, and the latest projections for more insights on the condition.

Prevalence and Demographics of Multiple Sclerosis 

In the U.S. alone, almost 1 million individuals suffer from this condition, which highlights its significant impact on public health. While MS can affect anyone regardless of age early onset usually affects those aged between 20 and 40, compromising an individual's quality of life during their prime working years.

• Every week, about 200 new MS cases are diagnosed in the U.S.²
• The multiple sclerosis market was worth $25.32 billion in 2021. It is projected to reach $33.98 billion by 2029, with a CAGR of 3.75% between 2021 and 2029.⁵
• The MS treatment market in the Middle East is projected to reach $4.5 billion by 2028, up from $2.3 billion in 2017.⁶
• The MS therapeutics market will expand from $31.03 billion in 2024 to an estimated $37.52 billion by 2029, with a projected CAGR of 3.87%.⁷
• The National Multiple Sclerosis Society U.K. Report, released in May 2022, reveals that more than 130,000 people with MS live across the U.K.¹⁶ 
• Approximately 7,000 individuals receive a diagnosis of MS within the country's borders each year.¹⁶
• According to the National MS Society, approximately 5,000 children and teenagers in the U.S.²
• Around 10,000 globally are currently diagnosed with MS.²

• The occurrence of MS in Australia has risen from 103.7 per 100,000 individuals in 2017 to 131.1 per 100,000 in 2021. The likely reason for this upsurge is linked to modifications concerning exposure levels toward established risk factors associated with MS development in humans.⁹
• There are over 33,300 individuals in Australia who have multiple sclerosis.⁹
• Every day, MS is diagnosed in one to two Australians.⁹
• Women comprise 75% of the total Australians diagnosed with MS.⁹
• It is estimated that in 2021, MS caused a cost of $2.449 billion to the Australian community.⁹
• The mean expense for MS per individual was $73,457 in the year 2021.⁹
• Compared to 2010, when lost wages comprised nearly half of the economic burden associated with MS, their contribution has now decreased to 29% among all categories.⁹

 In Inuit communities residing in the northernmost regions, also known as Eskimos, MS is remarkably infrequent. The frequency of MS remains lower in Asia. People of Northern European or Scandinavian origin are more prone to it than individuals of African descent, who have a lesser propensity for developing MS among Caucasians.

According to Dr. Tomas Kalincik, an expert from the University of Melbourne, MS is influenced by reduced exposure to sunlight, contributing significantly to its risk and severity.

Furthermore, individuals residing in such regions tend to be indoors for extended periods, increasing their vulnerability to viral infections like Epstein-Barr, which are linked with MS.

As per Dr Kalincik’s research findings, environmental factors besides genetic makeup or dietary habits accentuate greater prevalence coupled with a heightened intensity of MS occurrences amongst higher latitudes populations.

• With more than 90,000 individuals in Canada affected by MS at a rate of one person per every 400 residents, the country maintains its position among the nations with the highest incidence rates for this condition.¹⁰
• Every day, around 12 individuals are diagnosed with MS - a total of 4,377 people per year.¹⁰
• The diagnosis is typically made at the age of 43 years on average.¹⁰

Professor Mai Sharawy, a renowned neuro-ophthalmologist, highlights that MS necessitates considering genetic predisposition and environmental triggers. She advocates for policy changes to facilitate initial detection and treatment availability, particularly among low and middle-income countries, to guarantee optimal results globally for persons suffering from MS.

Multiple Sclerosis Progression and Impact Statistics

Individuals with MS have a life expectancy that is only slightly lower - around 5% less - than that of an average healthy adult.

15 years after being diagnosed with MS, roughly 50% of affected individuals will retain the ability to walk independently, while others may require assistive tools like wheelchairs.

It generally takes about 33 years for people living with MS to reach a significant disability stage that limits them from bed confinement and beyond.¹¹

These statistics highlight how steadily MS impacts the livelihoods of individuals and progresses over the years once diagnosed. 

• While MS is not inherited directly, individuals can inherit a genetic susceptibility to the disorder.³
• Children of individuals with MS have a significantly higher likelihood of acquiring the condition, up to 10-20 times greater than the general population. If MS afflicts one identical twin, there is a 25% possibility that the other twin will also be affected.²
• People with MS who experience severe disability have a quality of life that is 41% lower than those with MS but without disabilities.⁹

Despite ongoing research, the root cause of MS remains a mystery. Myelin damage to nerve fibers and neurons in the brain and spinal cord within the central nervous system is the ultimate cause. Still, a comprehensive understanding of the condition must be completed, including the potential influencers of genetic predisposition and environmental factors.²

Occurrence of Multiple Sclerosis

Clinically Isolated Syndrome (CIS)

It can be rephrased as a medical condition characterized by a single neurological episode. Although CIS is recognized as a component of MS, its progression to an actual degree program may only sometimes occur.

Lesions on the brain that can be identified through magnetic resonance imaging (MRI) indicate a high risk for developing MS. The National MS Society reports that individuals with such lesions have a 60-80% likelihood of being diagnosed with MS within a few years.

On the other hand, individuals who do not exhibit MRI-detected brain lesions are at low risk. However, they still face a 20% likelihood of being diagnosed with MS within an equivalent timeframe.²

MS with relapsing and remitting periods (RRMS)

RRMS is distinguished by evident relapses, which exhibit heightened disease activity and deteriorating symptoms. Consequently, there are intervals of remission where the ailment doesn't advance. During remission, symptoms can improve or disappear. As per the National MS Society, around 85% of individuals are initially diagnosed with RRMS.²

SPMS, an abbreviation for Secondary Progressive Multiple Sclerosis

Following an initial diagnosis of RRMS, SPMS may manifest. Disability can worsen gradually over time regardless of relapse occurrence or MRI scan variations. Furthermore, intermittent periods of stability and occasional relapses may arise.

If left untreated, approximately half of individuals diagnosed with RRMS will develop SPMS within ten years. Within 25 years, this proportion increases to about 90%.²

PPMS refers to Primary Progressive Multiple Sclerosis.

Approximately 15% of individuals with MS are diagnosed with PPMS, which entails a continuous advancement of the illness without discernible relapses or remissions. The incidence of PPMS is evenly distributed between genders.²

While the course of MS differs among people, there are typical patterns like relapsing-remitting, secondary progressive, and primary progressive. As time passes, MS can cause substantial physical and cognitive impairments that impact one's ability to move freely or control bladder/bowel movements while hindering memory retention or problem-solving skills.

Neurologist Dr. Stephen Hauser reveals that MS can strip patients of their basic abilities like vision, sensation, motor strength, or even independent speech and breathing.

His discoveries about B-cells' role in MS pathology led to a breakthrough that resulted in potential treatments targeting these cells, slowing down disease progression significantly.

Multiple Sclerosis Risk Factors Statistics

Over the last two decades, there has been significant progress in MS treatment. High-income countries offer a wide range of oral, intravenous, and injectable medications to combat this condition.

Unfortunately, low- and middle-income nations don't have access to most of these treatments; furthermore, progressive forms remain undertreated with limited therapeutic choices available for them.

The Intersectoral global action plan for epilepsy and other neurological disorders 2022–2031 received endorsement from the World Health Assembly in May 2022.

Its purpose is to confront worldwide challenges and gaps associated with treating individuals who suffer from conditions such as MS, ensuring a comprehensive response by coordinating efforts across sectors.¹²

• Cigarette smoking is associated with an increased risk of MS. Smoking women have a 1.6-fold higher likelihood of developing MS compared to non-smoking females. Moreover, those with MS who smoke are at a substantially elevated risk for accelerated disease progression.⁴
• Developing MS may be associated with parasites as a potential risk factor. Studies have indicated parasites can influence the immune system, reducing responsiveness. Those who harbor these organisms are less susceptible to being diagnosed with MS. At the same time, regions with a decreasing prevalence of parasites show increased diagnosis rates for this condition worldwide.⁴
• The estimated overall expense for MS in the U.S. was a staggering $85.4 billion in 2019, with direct medical and indirect non-medical expenses amounting to $63 billion and $22 billion, respectively.⁸
• Disease-modifying therapies (DMTs), including prescription drugs, constitute the highest proportion of these expenses, generating an estimated $38 billion annually. The cost per individual for MS medication spans from $57,000 to $93,000 on an annual basis.⁸
• Indirect costs refer to expenses that cannot be directly attributed, such as reduced work performance efficiency, nonattendance, and premature retirement caused by illness. The approximate amount of these charges was $21 billion in 2019.⁸
• Non-medical costs attributed to $742 million unrelated to medical care, such as home modifications, transportation, and paid caregiving.⁸

The occurrence of MS remissions and relapses can be influenced by pregnancy. Certain women may experience a reduction or alleviation in symptoms while pregnant. Still, there is a possibility for an aggravation after childbirth - termed postpartum relapse, which has been seen among MS researchers and patients.

According to Dr. Peter Calabresi, Ph.D. , director of the Johns Hopkins Multiple Sclerosis Center, women who have recently been diagnosed should contemplate taking part in clinical trials that focus on developing novel treatments and improving symptom control while pregnant.

This is especially informative due to the factors that trigger and affect individuals, particularly women.

Book a free consultation with us for a full-body checkup with an MRI. 

Frequently Asked Questions

Sources

1. Mayo Clinic
2. Healthline
3. National Institute of Neurological Disorders and Stroke (NINDS)
4. Multiple Sclerosis Association of America (MSAA)
5. Data Bridge Market Research
6. Statista
7. Mordor Intelligence
8. Neurology Live
9. MS Australia
10. MS Canada
11. Web MD
12. World Health Organization (WHO)
13. Yale Medicine
14. UCLA Health
15. Cleveland Clinic
16. MS Society

Dr. Michael Weiner, a leading expert on Alzheimer's disease, says: "Alzheimer’s disease is the most common cause of dementia, accounting for 60-80% of cases. It’s a gradual disease that slowly takes away memory and thinking skills, eventually stripping people of their independence and sense of self."

These diseases greatly affect the livelihoods of many people, so much so that by 2050, the number of people with dementia is projected to triple, reaching over 139 million worldwide. 

These symptoms occur when brain cells are damaged and can no longer communicate effectively, impacting thinking, behavior, and emotions. 

In this article, we’ve sourced the most important and intriguing statistics on Dementia and Alzheimer's to provide a heightened understanding of how these diseases impact people.

Dementia and Alzheimer’s by Demographics 

It’s often thought that dementia and Alzheimer’s disease only affect elderly people. However, with extensive research on the subject, we can see that this isn’t the case. In fact, during our lifetime, half of us will experience the effects of dementia.⁶ 

While the majority are aged over 65, early-onset Alzheimer’s has been observed in younger adults in their 30’s, 40's, and 50’s.

According to Dr. Helena Chang Chui, chair of Neurology at Keck Medicine of USC,

Here’s a complete list of statistics related to dementia and Alzheimer’s based on demographics.  

• The number of individuals globally experiencing dementia is surpassing 55 million. ²
• An estimation has projected that by 2050, this figure will surge to about 139 million individuals diagnosed with dementia, with low and middle-income countries expected to encounter the most substantial increments.²
• At present, low and middle-income countries are home to 60% of individuals with dementia. This percentage is anticipated to rise to 71% by 2050.²
• Dementia is diagnosed once every 3 seconds in some parts of the world.²
• Approximately 75% of people with dementia across the globe remain undiagnosed.²

Paola Barbarino, CEO of Alzheimer’s Disease International, further emphasizes, “Healthcare systems' lack of awareness and the stigma around dementia are making it hard to support those living with it. Misunderstandings, insufficiently trained specialists, and limited access to diagnostic tools have led to shockingly low diagnosis rates.”

• Approximately 80% of the population feels concerned about developing dementia at some point in their lives, and one out of four individuals holds on to the belief that there are no preventive measures available.²
• 62% of healthcare professionals worldwide hold the inaccurate notion that dementia is a natural aspect typically associated with aging.² 

• By the end of 2024, the number of individuals diagnosed with all types of dementia in Australia is expected to surpass 421,000. Furthermore, this value is predicted to surge to over 812,500 by 2054.⁵
• By the end of 2024, it is projected that almost 29,000 individuals will be residing with younger onset dementia in Australia. This number is expected to surge beyond 41,000 by 2054.⁵

Dr. McCabe’s findings indicate an urgent need for early detection tools, increased awareness, and better support systems to manage the growing demand for dementia care in younger populations.

• Moderate to severe cognitive impairment (such as forgetting simple conversations to severe personality changes) is present in over two-thirds (68.1%) of aged care residents.⁵
• It is believed that two out of every three individuals with dementia reside in the Australian community.⁵
• The estimated number of individuals living with dementia in the U.K. is 944,000 people.⁶
• Women account for 65% of the U.K.'s 944,000 population living with dementia.⁶
• In the U.K., dementia affects 1 out of every 14 individuals who are over the age of 65.⁶

According to Alzheimer’s Research UK, participation in a dementia clinical trial is currently limited to only 1% of the eligible population. Recruiting sufficient participants for such trials can take up to three years, while equivalent efforts in cancer research yield completed results within just 2.3 years. The question is, why is that the case?

Despite the absence of a treatment that modifies all causes of dementia, only 2% of England's diagnosed population with this condition are enrolled in Join Dementia Research. This organization connects individuals to research on dementia in the U.K.

• Young onset dementia is estimated to affect 70,800 individuals in the U.K.⁷
• The estimated number of people living with dementia in Northern Ireland is 13,625.⁶
• Among U.S. adults, Alzheimer's disease ranks as the sixth major cause of death.¹³
• It is estimated that by 2060, the number of people suffering from Alzheimer's disease will increase to approximately 14 million individuals, with minority groups being disproportionately impacted.¹⁶
• Today's estimates for Hispanic cases will be multiplied by seven in the future.¹⁶
• Estimates for cases among African Americans will be four times higher than those projected today.¹⁶

The impact of dementia and Alzheimer's disease is significant for both individuals and society. This is expected to almost triple by 2050 due to aging populations, affecting millions of people globally. Efficient management strategies require early diagnosis, risk factor control, and robust support systems for caregivers worldwide.

Dr Emma Nichols, a researcher from the Institute for Health Metrics and Evaluation, says, "Our study offers improved forecasts for dementia on a global scale... These estimates can be used by national governments to ensure resources and support are available for individuals, caregivers, and health systems globally."

With the ongoing increase of individuals at risk for developing dementia or Alzheimer’s, it’s important to understand how they can best be supported by caregivers (friends or family) and the health system.

Types of Dementia and Alzheimer’s Disease Statistics

According to Alzheimer's Research UK's most recent findings, addressing specific risk factors in our daily routines could prevent or delay as many as 40% of dementia cases worldwide.

These statistics share an overview of the types of dementia people face globally.

• Out of every 100 individuals with dementia, approximately 20 are estimated to have vascular dementia, which ranks as the second most frequent form of this condition.⁸

It’s intriguing to observe the correlation between dementia and other cardiovascular diseases. In a podcast with Dr. William Li, an expert in cardiovascular and metabolic health, he explained, “and so vascular dementia is the most common cause of dementia. To clarify, vascular dementia is the brain part of narrowing of the arteries that can occur in other parts of your body, including your heart.” 

100 Cardiovascular Disease Statistics: Death Toll, Demographics, Risks, and Costs

Did you know heart and circulatory diseases cause 1 in 3 deaths worldwide?

Aeon BlogShanal Govender

He continued that,

• The third most common cause of dementia is linked to various diseases, including dementia with Lewy bodies.⁹
• Approximately 10-15 out of every 100 individuals with dementia are affected by Lewy body dementia, indicating a total count of approximately 100,000 U.K. residents living with this form of cognitive impairment.⁹
• Parkinson's disease (PD - a chronic and progressive neurological disorder that primarily affects movement) is closely linked with dementia with Lewy bodies. The accumulation of Lewy bodies - seen in Parkinson's as well - triggers symptoms such as tremors and issues related to movement.⁹
• About 24% to 50% of individuals with PD have dementia, which constitutes roughly 3% to 4% of the total population's cases.¹⁰
• Typically, movement symptoms of PD emerge in individuals aged between 50 and 85 years old; however, certain people may exhibit indications at a younger age.¹¹
• Eventually, dementia develops in up to 80% of individuals with PD.¹¹
• It takes approximately 10 years from the initiation of motor symptoms to manifest dementia on average.¹¹
• Studies indicate that the longevity of an individual living with Parkinson's disease dementia (PDD) typically ranges from five to seven years, yet this may differ depending on each person's circumstances.¹¹

Due to similar symptoms, it is often challenging to clinically distinguish between Frontotemporal Dementia (FTD) and Alzheimer's Disease. However, utilizing Fractional Anisotropy (FA) measurements from Diffusion Tensor Imaging (DTI) can aid in distinguishing the distinct degradation of white matter patterns associated with each dementia type.

• Education and cognitive stimulation play a crucial role in dementia prevention. By attaining higher education levels and engaging in cognitive activities throughout one's lifetime, up to 7% of dementia cases could be prevented.¹²
• Addressing hearing loss during mid-life (45-65) can prevent or delay approximately 8% of all dementia cases.¹²
• Smoking could be attributed to 5% of dementia cases.¹²
• Potentially, traumatic brain injuries (TBI) can be attributed to 3% of all cases of dementia.¹²

Repeated head injuries, especially in athletes and military personnel, increase the risk of FTD by causing cumulative brain damage. Additionally, genetic factors might make some people more vulnerable to developing FTD after experiencing TBI.¹⁷

• Approximately 60% of individuals diagnosed with Frontotemporal Dementia (FTD) fall within the age range of 45 to 60.¹⁷
• In a comprehensive analysis, FTD represents roughly 3% of dementia cases among studies involving people aged over 65 and approximately 10% in investigations conducted exclusively on those younger than that age group.¹⁷

A single autopsy study revealed that out of 447 elderly individuals who were thought to have Alzheimer's disease at the time of death, only 3% displayed the brain alterations characteristic of Alzheimer’s. Conversely, approximately 15% exhibited signs consistent with different types of dementia. In comparison, a staggering majority- roughly 82%- showed evidence pointing towards both Alzheimer's and another type of dementia simultaneously (also known as Mixed Dementia).¹⁷

Addressing these factors has the potential to prevent or postpone dementia. This not only benefits individual health but is also significant for public health. With a growing elderly population, lowering the incidence rates of dementia can ease the economic and societal strain of long-term care for patients with this condition.

Dementia and Alzheimer’s Mortality Statistics

The prevalence of dementia and Alzheimer's disease presents notable obstacles in the public healthcare sector. The occurrence rate of these conditions results in higher mortality rates. 

Therefore, physicians must lead this charge by creating intricate diagnostic protocols, pioneering innovative therapeutic techniques, and ensuring that all-encompassing care plans are readily available. 

• Globally, dementia is the seventh most prevalent cause of death.⁴
• Dementia affects women more severely than men. ⁴

This is interesting, considering we don't know why, but estrogen is believed to play a protective role in brain health. After menopause, women experience a significant drop in estrogen levels, which may contribute to an increased risk of dementia.

• Women have higher rates of disability and death from dementia. Additionally, women provide 70% of the care for people with dementia.⁴

According to an article in The BMJ, this is likely due to biological, social, and cultural factors. Women generally live longer than men, increasing their chances of developing dementia. Socially, women are more often caregivers, so they take on the majority of caregiving responsibilities for those with dementia​.

• According to provisional data, dementia is fast becoming the primary cause of death for all Australians after already claiming second place due to factors such as an aging population, increased awareness, and diagnosis; advances in healthcare have led to a decline in mortality, chronic health conditions, and lifestyle factors .⁵
• Dementia was the primary cause of mortality in the U.K. in 2022, resulting in over 74,000 fatalities (constituting 11.3% of all deaths). This marked a rise of an additional 5,000 individuals who succumbed to dementia as compared to the previous year.⁷

• From 2000 to 2019, fatality rates linked with stroke, heart disease, and HIV declined, while there was a surge of over 145% in reported fatalities due to Alzheimer's disease (AD). It is probable that the COVID-19 outbreak during the years 2020 and 2021 only aggravated this trend.¹⁵

In a TedTalk hosted by Alanna Shaikh, a global health consultant, she mentions how dementia took its toll on her father and their family. "I'm doing everything I can to prevent getting Alzheimer's. I'm eating right, exercising daily, and keeping my mind active. That's what the research says I should do. But the research also shows that nothing will 100% protect you. If the monster is in you, the monster can get you. That's what happened with my dad. My dad was a Bilingual College Professor."

What is the likelihood of inheriting dementia?

Understanding the Causes of Dementia

Explore the diverse causes of dementia, from neurodegenerative processes to vascular issues.

Aeon BlogCarolin Kaulfersch

• Sporadic Alzheimer's, which accounts for roughly 95 to 99% of cases, typically arises from a multifactorial combination of genetic variations, environmental factors, and lifestyle. Advancing age is the most influential risk factor in sporadic Alzheimer's onset. Although not direct causes themselves, certain susceptibility genes such as ApoE4 can elevate one's future likelihood of developing this condition.¹⁹
• There are three common variants of the ApoE gene: ApoE2, ApoE3, and ApoE4. The E4 variant raises the chances of developing Alzheimer's disease, but its absence does not prevent one from acquiring it. Notably, many individuals carrying the E4 variant do not develop Alzheimer's, even in old age.¹⁹
• Familial Alzheimer's Disease (FAD), which comprises 5% of all cases, is characterized by a genetic predisposition. The three genes associated with FAD are APP, PSEN1, and PSEN2—the "Alzheimer's genes." If one parent carries a mutated form of any of these genes, their children have an even chance (50%) to inherit it. Individuals carrying the inherited mutation will develop FAD themselves, typically before age 65.¹⁹
• There is a genetic component to Frontotemporal dementia (FTD), with approximately 10% of cases categorized as hereditary familial forms.¹⁹

Dr. Howard Rosen, a neurologist at the UCSF Memory and Aging Center, states, “About 10-20% of all FTD cases are considered genetic, caused by a single gene mutation inherited in a dominant pattern.” If a parent has the mutation, there is a 50% chance their child will inherit the condition​.

Dementia and Alzheimer’s Market Statistics

The dementia and Alzheimer’s market is anticipated to grow to $13 billion, up from $7.5 billion in 2019, thanks to improvements in diagnostic technologies, innovative therapies, and an ascending cognizance and diagnosis rate for Alzheimer's disease worldwide.

The following statistics showcase the growth and expansion of this market, as well as areas for improvement in clinical trials, treatment options, and specialist care for people with the disease.

• In 2015, dementia expenses totaled $818 billion, comprising a 1.09% share of the worldwide GDP. ³
• Currently, there has been an upsurge, with annual costs exceeding $1.3 trillion, and they are projected to rise even further, reaching $2.8 trillion by the year 2030.³
• The projected expenses for dementia in the U.K. amounted to £25 billion in 2021. ¹¹
• It is projected to rise to  nearly £47 billion by 2050.¹¹
• In 2018, the cost of dementia worldwide was approximated at $1.3 trillion and is expected to increase significantly in coming years due to an estimated triple growth in individuals afflicted with this condition by 2050.¹¹
• Dementia expenses are forecasted to increase significantly by 2050, with costs rising from £25 billion in 2021 to approximately £47 billion.¹¹
• The total cost of informal care for dementia in the U.K. amounts to £10.2 billion.¹¹
• In 2010, it was estimated that the expenses for managing Alzheimer's disease would range from $159 to $215 billion. However, by 2040, these costs are predicted to soar and fall between an annual figure of $379 and over $500 billion.¹³
• Medicare and Medicaid are anticipated to cover $231 billion (64%) of the expenses, while $91 billion will likely come from out-of-pocket spending.¹⁴
• It is expected that by 2050, the combined expenditure on health care, long-term care, and hospice services for individuals living with dementia will reach a staggering $1 trillion.¹⁴
• It was projected that the combined cost of healthcare, long-term care, and hospice services for individuals aged 65 years or older with dementia amounted to $345 billion by the end of 2023.¹⁵

She added that, "As we approach a projected $345 billion in combined care costs by the end of 2023, it's clear that urgent action is needed to develop effective treatments and support systems for those affected by dementia."

Dementia and Alzheimer’s Caregiver Statistics

In the U.S., there is a severe shortage of caregivers. The need for home health aides and personal care aides is expected to grow by 34% between 2019 and 2029, making it one of the fastest-growing professions. 

This rapid growth is largely propelled by an aging population and heightened healthcare capabilities, causing longer lifespans that generally support long-term patient continuing attention needs, particularly those privately owned chronic medical illnesses.

• Globally, 35% of caregivers have kept the diagnosis of dementia for a family member concealed.²
• More than half of caregivers worldwide indicate a decline in their health resulting from their duties, even though they express satisfaction with their role.²
• Approximately 20% of the total expenses related to dementia are attributed to direct medical care costs, and approximately 40% is accounted for by both direct social sector costs and informal caregiving expenses.³
• Over 1.6 million individuals in Australia are involved in the care of someone living with dementia.⁵
• People providing unpaid care for those living with dementia spend 1.1 billion hours each year on this task.¹¹
• According to a survey, 55% of primary care physicians (PCPs) who attend to individuals with Alzheimer's disease note that there is an insufficient number of dementia specialists available in their localities.¹⁴
• Direct care workers have high turnover rates, with home care providers estimated at 77% annually and nursing assistants in nursing homes at a staggering 99%.¹⁴
• To effectively care for the projected number of people with Alzheimer's in 2050, the U.S. will need to increase its count of geriatricians (doctors who specialize in the care of older adults) by almost three times.¹⁴
• 70% of dementia caregivers express stress due to coordinating care.¹⁴
• Having access to a care navigator would influence the choice of dementia healthcare provider for the person they take care of, according to 85% of dementia caregivers.¹⁴

In fact, Dr. Sam Fazio, Director of Quality Care and Psychosocial Research at the Alzheimer’s Association, emphasizes the holistic approach of dementia care navigation: "Dementia care navigators play a critical role in delivering comprehensive care that addresses the medical, legal, financial, and emotional needs of individuals with dementia and their caregivers. They facilitate coordination and engagement across all facets of care to overcome the barriers faced by this population."

• 61% of dementia caregivers think that a care navigator (also known as a patient navigator, is a professional who helps patients and their families navigate the complex healthcare system) would enhance the quality of life for their recipients. 43% also believe that it can lead to overall improvement in health conditions.¹⁴
• 62% of dementia caregivers believe a care navigator would help them achieve less stress and more peace of mind.¹⁴
• 56% of caregivers believe that having a care navigator would improve their caregiving abilities.¹⁴
• Individuals with Alzheimer's or other forms of dementia experience twice the number of hospital visits annually compared to elderly individuals.¹⁴
• Out of ten caregivers who provided care for individuals with Alzheimer's or other types of dementia, six had employment recently or in the past year. They worked an average of 35 hours per week while taking on caregiving responsibilities.¹⁷
• Of those who provided care for someone with Alzheimer's or another dementia while working in the last year, 57% acknowledged requiring occasional late arrival or early departure from work as opposed to 47% of non-dementia caregivers.¹⁷
• Those caring for individuals with dementia had a higher percentage of reduced work hours due to caregiving responsibilities (18%) in comparison to non-dementia caregivers (13%).¹⁷
• Each year, Medicare beneficiaries with Alzheimer's or other dementias experience an average of 1,545 emergency department visits per 1,000 individuals. This count covers all emergency room visits that lead to hospital admissions.¹⁷
• Medicare beneficiaries diagnosed with Alzheimer's or other forms of dementia have 2.7 times higher prevalence rates of four or more chronic conditions (excluding the specific diagnosis) than those without any form of dementia, on average.¹⁷

Ultimately, caregivers are necessary, making the disease easier to bear with a familiar helping hand.

If you are interested in a full-body checkup with an MRI, please book a free consultation here.

Frequently Asked Questions

Sources

1. Keck Medicine of USC
2. Alzheimer’s Disease International
3. Alzheimer’s Disease International
4. WHO
5. Dementia Australia
6. Alzheimer’s Research UK
7. Alzheimer’s Research UK
8. Alzheimer’s Research UK
9. Alzheimer’s Research UK
10. The National Center for Bitechnology Information (NCBI)
11. Dementia Statistics Hub
12. Dementia Statistics Hub
13. CDC
14. Alzheimer’s Association
15. The National Center for Bitechnology Information (NCBI)
16. CDC
17. Alzheimer’s Association
18. Alzheimer’s Disease International
19. Jama Network

It was done by Physicist Isidor Isaac Rabi, who later won a Nobel Prize in 1944 for his "resonance method for recording the magnetic properties of atomic nuclei."

In an interview with News Medical in 2023, Brad Sutton, a professor of bioengineering at the University of Illinois at Urbana-Champaign, explains that: "[Magnetic Resonance Imaging] MRI has become one of the most important tools for doctors to see inside the body and understand what is happening in disease."

Sutton added, "In the next few years, we will see new MRI systems with even higher magnetic fields, providing even higher spatial resolution images of the body and brain."

In modern medicine, MRI is a handy tool for diagnosis. We offer whole-body MRI, allowing you to identify your risk factors early. 

 To help you better understand MRIs, we have compiled a list of the latest MRI trends and stats.

MRI Usage Statistics

As noted above, MRI is a very useful tool in the early detection of diseases. This is, among other things, true for people with Multiple Sclerosis (MS), a disease that damages nerves and makes it hard to communicate because it affects the brain and spinal cord. MS usually doesn't show signs, but MRI scans can show disease activity that regular tests might miss.

Dr. Timothy Vollmer, Medical Director of the Rocky Mountain MS Center, explains:

MRIs have proven pivotal in doctors' diagnosis and treatment plans. Many types of MRI are used for specific tests and to observe disease progression. 

• In August 2021, X-ray was the most common procedure, with 1.6 million procedures, followed by ultrasound with 0.72 million, CT scan with 0.49 million, and MRI with 0.29 million.¹²
• The time between requesting and performing a test in August 2021 varied widely. X-ray, Fluoroscopy, and Medical Photography were done on the same day, while MRI tests took up to 24 days.¹²

• The increasing development of intraoperative MRI and its use in various applications, like neurosurgery, is expected to drive market growth from 2024 to 2030.¹⁴
• Additionally, diffusion-weighted MRI is primarily used to detect a stroke within 30 minutes of it happening.¹⁴

A study in the JAMA Network looked at 135 million imaging exams in 7 US health systems and Ontario. It found that the yearly increase in imaging rates for CT and MRI scans among US adults and older adults slowed down over time.¹⁸

• For CT scans, the annual growth rate among adults dropped from 11.6% in 2000-2006 to 3.7% in 2013-2016, and for older adults, it dropped from 9.5% to 5.2%.¹⁸ 
• For MRI scans, the rate among adults fell from 11.4% in 2000-2004 to 1.3% in 2007-2016; for older adults, it decreased from 11.3% to 2.2%.¹⁸
• For children, the annual growth rate for CT scans either leveled off or dropped (in the United States: from 10.1% in 2000-2005 to 0.8% in 2013-2016; in Ontario: from 3.3% in 2000-2006 to −5.3% in 2006-2016). However, MRI trends were similar to those seen in adults.¹⁸
• Another study on utilization trends in LMICs found that from 2009 to 2019, the population in the Western Cape, South Africa, increased by 25%, and the total number of imaging investigations rose by 32%.¹⁹
• Between 2009 and 2019, the number of imaging tests per 1,000 people rose from 256 to 270. This is a 5% overall increase, averaging 1.4 additional tests per year per 1,000 people.⁹
• In the provincial US, the use of CT and MRI scans per 1,000 people between 2009-2019 increased significantly: CT by 111% (from 20 to 43 per 1,000), MRI by 78% (from 10 to 18 per 1,000), and other types of MRI by 32% (from 1.9 to 2.5 per 1,000).¹⁹ 
• Meanwhile, the use of fluoroscopy (from 3.6 to 3.7 per 1,000) and mammography (from 14.2 to 15.9 per 1,000 women aged 40-70) stayed about the same. However, plain radiography, which takes pictures of internal structures using X-rays, decreased by 20% (from 216 to 196 per 1,000).¹⁹
• MRI exams fell sharply during the first COVID-19 wave, with the most significant drop in April 2020. Compared to April 2019, there was a 47.5% decrease compared to April 2018 and a 42.2% decrease.²⁰
• The rate of MRI exams in Tel-Aviv compared to the Northern periphery increased from 2.89 in April 2019 to 3.94 in April 2020.²⁰
• In the Jerusalem metropolitan region with the highest number of COVID cases, MRI usage dropped by only 1% during the first ten months of the pandemic.²⁰

The growth in the MRI market mirrors trends seen in healthcare as a whole. This increase in MRI use is understandable because MRIs provide detailed images without invasive procedures or radiation, unlike X-rays and CT scans. This makes them essential for diagnosing and treating conditions, especially in neurosurgery and stroke detection.

MRI Statistics by Country

MRIs have changed and will continue to change how healthcare are supported and influenced globally. Current trends indicate a global disparity surrounding MRI availability in certain parts of the world. 

In 2023, Hilabi, B.S., et al. observed, "Although [MRI] was invented in 1974, access to this innovative and clinically valuable imaging technique remains limited in developing/underdeveloped countries. Its usage in LMICs is still somewhat limited compared to the industrialized world, and it continues to advance exponentially each year due to stronger magnets.”

• Over the previous six years, MRI exams climbed by 0.9% in Canada, whereas procedure volume expanded by 3%–4% in the US in 2021.¹³

Magnetic field strength (Tesla) T is used to categorize MRI machines: low-field MRIs have a field strength of less than 1.5 T, mid-field MRIs have a field strength of 1.5 T to 3 T, and high-field MRIs have a field strength of greater than 3 T.¹⁴

• In 2024, about 80% of MRI systems will be 1.5T. Most procedures will be led by the private sector. Advanced technologies and applications like point-of-care, pediatrics, dry magnets, compact MRI, and fusion imaging are driving the global market and will keep doing so in the future.¹³
• By 2024, partnerships between public and private sectors, along with local production by Extraocular Muscles (EOMs) (muscles within the orbit but outside the eyeball), are expected to significantly boost the use of 1.5T MRI equipment across Latin America.¹³
• North America dominated the world market in 2023 with a more than 36.74% share. The need for sophisticated imaging analysis is rising in this region due to the rising frequency of chronic illnesses such as neurological diseases, cardiovascular problems, and breast cancer.¹⁴
• Due to an aging population and growing demand for cutting-edge imaging technology, the Asia Pacific region is predicted to increase at the quickest pace, 7.4%, between 2024 and 2030.¹⁴
• MRI sales in India are expected to rise at a noteworthy 8.0% CAGR between 2024 and 2030.¹⁴

Significant differences exist between countries regarding how frequently and where MRI technology is available and used. The distribution of MRI machines is unequal, developed countries like Japan and the US possess more MRI machines than West Africa and Southeast Asia. 

Nigatu, A.M. et al. agree: "The challenge is very critical, especially for low—and middle-income countries (LMICs), due to inadequate infrastructure, lack of imaging technology, inaccessibility, affordability, acceptability, a shortage of radiologists, migration from low-income to high-income countries, and a lack of technical experts." 

The steady rise in MRI machines and processes in developed countries dramatically differs from the need for more access in less developed areas. As more improved imaging tools are used to diagnose chronic illnesses, fixing these problems will be important to achieving global health equity.

MRI Market Share and Size Statistics

Rising at a yearly rate of 2.5%, the MRI market is projected to reach $4.52 billion by 2024.¹³ As modern medicine advances, the size and proportion of MRI markets are expanding fast.

• In Japan and ASEAN, sales of new 3T machines in 2021 exceeded those in any other year. Sales of 1.5T machines likewise increased in China and India.¹³
• The global MRI market was valued at $6.64 billion in 2023. From 2024 to 2030, its annual growth rate is expected to be 6.5%.¹⁴

Rising spine lesions, tumors, and strokes are expected to expand the market further. 

• The National Center for Health Statistics stated that there were around 1,958,310 new cancer cases and 609,820 cancer deaths recorded in the United States in 2023. The increasing need for speedy and practical diagnostic procedures is also projected to drive the adoption of MRI equipment.¹⁴
• MRI diagnostic screening dropped 47.5% from 2019 to 2020 because of Covid-19.¹⁴
• In 2023, more than 75.47% of the market comprised closed MRI systems.¹⁴

Closed MRI devices use strong magnetic fields and high-frequency radio waves to produce clear pictures. Their enclosed form allows for the choice of exact picture slices. 

• From 2024 to 2030, open MRI systems are expected to grow at a CAGR rate of 7.7%. This is mainly because their open form makes patients feel less anxious and claustrophobic.¹⁴
• Around 12.5% of people experience Claustrophobia (fear of enclosed spaces) when considering an MRI. ¹⁷ 

In a YouTube video on 'How Open Upright MRI Helps Claustrophobic Patients', MRI technician Travis Gould assists in calming and supporting the patient as part of the Open Upright MRI of Missouri team of specialists,

"They come here because they have a problem, and we're trying our best to help out with whatever problem they have so we can get them onto the next part of their treatment because a lot of the time, they can't move on from here. I mean, you can have a CT [and] an X-ray, but an MRI is [the gold standard] of a lot of imagining because of the detail it brings." 

• The mid-field strength MRI segment had the largest share at 47.70% in 2023 and is expected to see significant growth from 2024 to 2030.¹⁴
• The high-field MRI segment is projected to grow at the fastest rate of 7.9% from 2024 to 2030.¹⁴
• In 2023, the hospital segment had the largest share at 37.87%, thanks to the growing number of MRI units installed in hospitals.¹⁴
• The MRI segment of imaging centers is expected to grow the fastest, with a rate of about 7.8% from 2024 to 2030.¹⁴
• MRI systems led the market in 2023, making up about 22.96% of the revenue. This dominance is due to the higher quality and detailed scans they provide compared to CT scans.¹⁴

• The global MRI market was worth $7.55 billion in 2022. It's projected to reach $11.07 billion by 2032, growing at a rate of 3.91% per year from 2023 to 2032.¹⁶
• In 2023, the market for MRI systems was worth $5.73 billion. It is projected to grow at a rate of over 4% per year from 2023 to 2033.¹⁵

The MRI market is changing dramatically because of new technologies and the need for accurate diagnosis. The growing inclination toward a more patient-focused approach to the MRI market helps with stressors like anxiety. This consideration, paired with the innovation of new MRI technology, has shown promise in the market.

MRI Technician Statistics

MRI technicians get paid differently depending on where they live and how many imaging techniques they have.

Radiologic technologists conduct imaging tests on patients to help diagnose medical conditions. MRI technologists specifically use MRI scanners to produce detailed diagnostic images.

• In May 2023, the median annual salary for MRI technologists in the US was $83,740, while radiologic technologists and technicians earned a median annual salary of $73,410.¹⁰
• Employment for radiologic and MRI technologists in the US is expected to grow 6% from 2022 to 2032, faster than the average for all jobs. On average, there will be about 15,700 job openings each year for radiologic and MRI technologists over this decade.¹⁰

• Most MRI technologists are White, making up 69.7% of the US population. Hispanic or Latino MRI technologists account for 11.0%, while Asian MRI technologists make up 10.4%.²¹
• Black or African American MRI technologists have the lowest average salary at $88,924.²¹

Former US Veteran and registered MRI, CAT scan, and X-ray Technician Tracy Walker advises viewers on his YouTube channel on how much a technician should be getting paid in Texas: “MRI [technicians] should be getting paid $35 [an hour] and up. Do not let anyone pay you less than that.” 

He further advises,

• Most MRI technologists are over 40 years old, making up 65% of the total population in this field in the US.²¹
• The most common degree for MRI technologists is an associate degree, held by 56% of them. The second most common is a bachelor's degree, held by 27%, followed by another bachelor's degree category at 3%.²¹
• MRI technologists in California earn the highest salaries, averaging $100,572 a year.²¹

MRI and radiologic technologists are in high demand, and the job market is growing quickly. More and more people from different educational backgrounds are working in this field, and their importance to modern healthcare influences the demand for skilled technicians. 

MRI Machine Statistics

There are many MRI types, each used for different kinds of imaging. The number of MRI machines available globally is increasing, similar to the growth in MRI market share compared to CT and X-ray machines.

• In 2020, Japan had 7,240 MRI scanners, an increase of 244 scanners (3.49%) since 2017. Although growth slowed, this is the highest number of MRI scanners recorded during the observed period.⁷
• In 2021, there were about 5,800 MRI units worldwide. Market research company Next Move Strategy Consulting predicts that this number will surpass 10,700 by 2030.⁸
• Japan has the highest number of MRI units among Organisation for Economic Co-operation and Development (OECD) member countries, with over 57 units available per million people.⁹
• The United States and Korea have about 28 and 36 MRI units per million people, respectively. In contrast, Mexico and Colombia have around 3 and 0.2 MRI units per million people.⁹
• In 2016, over 370 million people in West Africa had access to just 84 MRI facilities, with more than two-thirds of these units in Nigeria.¹¹
• In 2017, the African region had the fewest MRI scanners per million people (0.7), followed by the Southeast Asian region (1.1), the Eastern Mediterranean region (2.8), and the Americas (4.1).¹¹
• In 2017, the Asia Pacific region had the highest number of MRI scanners per million people, with 5.4 scanners.¹¹
• In England, 40.3 million imaging tests were reported between September 2020 and August 2021. Out of these, 3.22 million tests were conducted in August 2021.¹²
• The number of imaging tests is on the rise in England. According to a report by the NHS, England recorded 44.0 million imaging tests leading up to March 2022, a 26% increase from the 34.9 million tests performed the previous year.²⁹

• The number of MRI scanners in the United Kingdom stayed about the same in 2014 as it was in 2013, with roughly 467 scanners. However, 2014 still marked the highest number of MRI scanners in the UK at that time.³⁰
• In 2021, the number of MRI scanners in Germany remained steady at about 35.25 scanners per million people, the same as in 2020. Despite no significant change from the previous year, this still marks a peak for MRI scanners in Germany at 35.25 per million inhabitants.³¹
• In 2019, Denmark had the most CT scanners in hospitals among EU countries with data, with 4.0 scanners per 100,000 people. Cyprus followed with 3.5 scanners, then Bulgaria with 2.9, and Italy and Sweden both had 2.6. Romania had the fewest CT scanners per 100,000 people with 0.9, followed by France with 1.1, and the Netherlands, Poland, and Slovakia each had 1.4.³²
• In 2019, Finland had the highest availability of MRI units, with 2.9 units per 100,000 people. Cyprus followed with 2.0 units, Italy with 1.8, and Sweden with 1.7. Slovakia and Romania had the lowest availability, with 0.4 units per 100,000 people, followed by Bulgaria, Latvia, and Poland, each with 0.6 units.³²

The number and availability of MRIs clearly vary around the world, mainly due to MRI disparity. However, the growing healthcare field creates a market opportunity for MRI in LMICs. Imaging services are crucial for diagnosing and treating the increasing number of non-communicable diseases (NCDs) in these regions, as well as many infectious diseases such as tuberculosis and COVID-19.

Hilabi, B. S. et al. suggest: “[making] MRI facilities more accessible in developing countries, it is imperative that training programs be generated and additional resources be deployed. This is because charging patients for an MRI at the same price as in industrialized nations would be improper. It is essential for the healthcare delivery systems in the developing world to improve access to MRI for advanced medical imaging.”

MRI Cost Statistics

Despite the many advantages of MRI systems, the high costs of purchasing and installing these machines are affecting market growth, particularly in developing regions.

Did you know that Norwegian law requires doctors to assess the costs and benefits of medical treatments before patients receive them? To do this properly, doctors need to be well-informed about these benefits and costs.

In 2006, the Research Institute of the Norwegian Medical Association surveyed 1,400 Norwegian physicians, asking them to estimate the total cost of a standard MRI examination of a knee, including both patient payments and the standard fee reclaimable from health authorities.

Melberg, H. O, and Bringedal, B. found that: 

• 57% of respondents either overestimated or underestimated the actual price of 1250 NOK (approximately $118) by 50% or more.
• The most common mistake was overestimating the cost: 47% thought it was over NOK 1875 (approximately $176), while 10% believed it was under NOK 625 (approximately $59).

In short, Melberg and Brigedal deduced that doctors don’t actually know the costs of MRI exams and say: “doctors should know more about costs. They cannot fulfill their role as gate-keepers without such knowledge.”

A single MRI scan can cost up to $4,000, twice that of a CT scan.^9,23

MRI scans are mainly used to image organs, soft tissues, ligaments, and other hard-to-see parts of the body. In contrast, CT scanners are more commonly used to view bony structures.

• An MRI scanner is a significant investment for a practice or hospital, with prices ranging from $150,000 to several million dollars.⁹
• The average cost of a low- to mid-strength MRI machine is over $1 million.¹⁴
• A knee MRI in the United States usually costs between $500 and $3,000.²²
• The cost of a knee MRI varies a lot depending on the state. It ranges from $427 in Oklahoma to $1,191 in Alaska. On average, though, it costs $788 nationwide, according to Healthcare Bluebook.²²

Dr. Jason Whealing, B. Chiro SC, M. Chiro, founder of the blog site Physickle, advises that if you are low-income or using Medicare/Medicaid, "The MRI might be around $200."

• Under Original Medicare, you'll have to pay 20% of the cost for an MRI if you haven't met your deductible yet.²³
• In Oklahoma, the average cost of a knee MRI is $427, while in Alaska, it's $1,191.²²

Here's the average cost range for MRI scans across the USA:

1. Cervical Spine: $1,400 – $7,600.²²
2. Shoulder, Hand, Arm: $1,050 – $7,000.²²
3. Brain: $1,600 – $8,400.²²

• An MRI in Texas is about $1,000. However, it can range from $500 to $3,000. Where the MRI is done, the kind of institution, and if you have health insurance will all affect the precise cost.²²
• A knee MRI in California runs from $500 to $3,000, with an average cost of around $1,100.²²
• A knee MRI in New York usually runs $1,200. However, rates range from $500 to $3,000.²²
• Medicare.gov claims that an outpatient MRI scan runs, on average, around $17. The average cost is $9 if you obtain the MRI when hospital admission is in progress.²³
• Without insurance, a brain MRI can cost about $4,000.²³
• Another study found that the price of a hip MRI in Iowa varies greatly, from $485 to $4,463.²³
• The new MRI machine in India costs about ₹18.4 lakh ($22,000), roughly 50 times cheaper than traditional MRI machines ranging from ₹9 crore to ₹13 crore.²⁴

• In 2014, the U.S. conducted more MRI exams than many other wealthy countries, with each MRI costing an average of $1,119. This price was 42% higher than in the United Kingdom, 122% higher than in Switzerland, and 420% higher than in Australia.²⁵
• In 2017, an MRI scan cost an average of $1,430 in the United States.²⁶
• As of 2017, an MRI in the Netherlands cost $190.²⁶

A study in the JACR looked at 102,717 patients (average age 45.6 years; 64.8% women; 58.8% White) who had 229,010 imaging exams between 2000 and 2019. ²⁷

• During this period, the average costs for mammography, radiography, and ultrasonography rose by 14.5%, 24.5%, and 40%, respectively, while the average cost for CT or MRI scans dropped by 15.1%. Additionally, 51% of patients had out-of-pocket expenses.²⁷
• Out-of-pocket costs for imagining exams rose by 89.8% from 2000 to 2019.²⁷
• The average out-of-pocket cost for mammograms dropped by 32.9%. Meanwhile, the average cost for X-rays, ultrasounds, and CT or MRI scans increased by 81%, 123.2%, and 61%, respectively.²⁷

MRI costs can be quite high, especially in the United States. Despite the cost, MRI scans have increased (as we have established above) due to their importance in diagnosing various health conditions.

In the case of high costs, LMICs share a common challenge in the field of MRIs. Countries like Northwest Ethiopia practice severe cost savings for digital image consults via telegram. A radiologist key-informant remarked that having access to the digital image consultation made examining the patient much easier.

The Telegram consultation option allowed patients to save on costs related to accommodation and transportation because it was a free consultation service at a distance provided by the social relationship between the referring clinicians and the radiologist.

Although this sounds positive, drawbacks like remote location or security issues almost always turn imaging technicians away.

The fact remains that MRIs and the imaging service costs associated with them are high, and not everyone can afford them, even with insurance.

If you’re interested in a full body scan without the expensive price point, book a scan with us today. 

Frequently Asked Questions

Sources

1. A Review of Magnetic Resonance (MR) Safety
2. Magnetic Resonance (MRI) Frequently Asked Questions (FAQ)
3. MRI FAQs
4. What does 'End of Life' mean for MRI scanners?
5. MRI FAQs: Everything You Want to Know
6. This Month in Physics History
7. Number of magnetic resonance imaging (MRI) units installed in Japan from 2002 to 2020
8. Number of magnetic resonance imaging (MRI) units worldwide from 2021 to 2030
9. Number of magnetic resonance imaging (MRI) units in selected countries as of 2021
10. Radiologic and MRI Technologists
11. Impact of Magnetic Resonance Imaging on Healthcare in Low- and Middle-Income Countries
12. Diagnostic Imaging Dataset Statistical Release
13. Global Trends for MRI
14. Magnetic Resonance Imaging (MRI) Market Size
15. Magnetic Resonance Imaging (MRI) Systems Market Report Overview
16. Magnetic Resonance Imaging Market
17. Claustrophobia
18. Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016
19. Trends in public sector radiological usage in the Western Cape Province, South Africa: 2009–2019
20. National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic
21. MRI Technologist Demographics and Statistics in The US
22. How much do Knee MRIs cost? (2023)
23. Will Medicare Cover My MRI?
24. Low-cost MRI Machine
25. How do healthcare prices and use in the U.S. compare to other countries?
26. Average prices of a magnetic resonance imaging (MRI) in selected countries in 2017
27. Out-of-Pocket Expenditures for Imaging Examinations
28. Magnetic Resonance Imaging
29. Diagnostic Imaging Dataset Annual Statistical Release 2021/22
30. Magnetic resonance imaging (MRI) units in the United Kingdom (UK)
31. Magnetic resonance imaging (MRI) scanners in Germany
32. Availability of CT and MRI units in hospitals

Dr Danielle Stowasser explains, "Diabetes causes high levels of glucose (a type of sugar) in the blood. There are three main types of diabetes: type 1 and type 2 diabetes, which are lifelong conditions, and gestational diabetes, which only occurs in women during pregnancy.” 

She also added,

Many health professionals have now realized the need to implement new solutions for managing and preventing Diabetes.

In this article, we’ve sourced the most interesting and informative diabetes stats to provide more insights. 

Diabetes Statistics by Demographics 

It’s often thought that Diabetes is a lifestyle disease that affects middle-aged people. However, with abundant research on the subject, we can see that this isn’t the case. 

Dr Danielle Stowasser states, “It’s becoming more common in children and adolescents.” 

It is estimated that around 352,000 Americans under the age of 20 have been diagnosed with diabetes, representing approximately 0.35% of their population. ³

Here’s a complete list of statistics related to diabetes based on demographics.  

• The global prevalence of prediabetes was estimated to be 319 million people (6.2%) in 2021 and is projected to rise to 441 million (6.9%) by 2045. ¹
• Diabetes prevalence is higher in urban areas (10.8%) compared to rural areas (7.2%) and higher in high-income countries (10.4%) compared to low-income countries (4.0%). ⁶
• Diabetes has reached epidemic levels, with almost half a billion people globally being victims of the disease. ⁶
• More than one in three adults have prediabetes. ²

• In 2022, the total estimated cost of diagnosed diabetes was $412.9 billion, which includes $306.6 billion in direct medical expenses and $106.3 billion in lost productivity. ³
• Among people aged 65 years or older, 26.4 million (48.8%) have prediabetes. ⁵
• Many individuals taking high blood pressure medication have diabetes (41.2%), as well as those taking any medication in general (37.1%). ⁴
• An estimated 8.7 million people are living with type I diabetes around the world.⁹
• If all patients with type I diabetes are identified promptly, 668,000 more lives would be saved by 2040.⁹
• 22.8% of adults with diabetes remain undiagnosed.¹⁰
• 1.7 million adults (5.7% of those with diagnosed diabetes) have type I diabetes and use insulin.¹⁰
• There are 18,169 children and adolescents under 20 years old with type I diabetes.¹⁰
• More than 95% of diabetes patients have type II diabetes.¹²

• Adults with diabetes have a significantly higher risk of dying from a heart attack or stroke.¹⁴
• Diabetes is responsible for 44% of all new cases of kidney failure.¹⁴
• Annually, diabetes leads to approximately 73,000 lower limb amputations, representing 60% of all non-traumatic lower limb amputations.¹⁴
• Over 25% of Americans with diabetes suffer from diabetic retinopathy, which can lead to vision loss and blindness.¹⁴
• Each year, nearly 50,000 Americans start treatment for kidney failure due to diabetes.¹⁴
• Diabetes impacts various bodily functions, leading to diverse medical costs across different specialties, as reported by the ADA:
  • 30% of diabetes-related medical costs are linked to circulatory issues that reduce limb blood flow.¹⁴
  • 29% of diabetes-related medical costs are for kidney conditions.¹⁴
  • 28% of diabetes-related medical costs are for conditions affecting the nervous system.¹⁴

Andrea Francis, MS, RD, LD, MLDE, CDCES, a registered dietitian and licensed diabetes educator at the Barnstable Brown Diabetes Center said in an interview,

She went on to add that, “Education is an essential part of being able to navigate the ins and outs of diabetes care.”   

• Women without prior diabetes can develop gestational diabetes during pregnancy. Between 5% and 9% of pregnancies in the U.S. are impacted by this condition annually.¹
• Annually, gestational diabetes affects 2% to 10% of pregnancies in the U.S.¹⁸
• Approximately 50% of women with gestational diabetes eventually develop type II diabetes.¹⁸
• The estimated global prevalence of gestational diabetes is around 4.4%.¹⁹
• In the U.S. and Canada, gestational diabetes prevalence is 11.8% with a one-step screening method and 5.0% with a two-step method, averaging 5.9%. This average is higher than that of those from Europe (5.4%) and globally (4.4%) but lower than that of Eastern and South Eastern Asia (10.1%).¹⁹
• About 70% of women with gestational diabetes may develop type II diabetes, especially within the first five years post-pregnancy. The risk levels off after about ten years. However, a diagnosis of gestational diabetes presents a chance to implement preventive measures against type II diabetes.¹⁹
• It is estimated that 14% of pregnant women globally have gestational diabetes, though variations in screening and diagnostic standards lead to differing prevalence rates.¹⁹
• Individuals with diabetes are two to three times more likely to experience depression compared to those without diabetes. Additionally, they have a 20% higher chance of suffering from anxiety than people who do not have diabetes.²⁰
• Approximately one in eight women with gestational diabetes experience symptoms of depression following childbirth.²⁰

Dr. Lois Jovanovič, an expert in gestational diabetes, suggests asking your doctor,

She also warns that gestational diabetes could be undiagnosed type II diabetes and that consistent monitoring of blood sugar levels after pregnancy is necessary.    

Diabetes Death Rate Statistics

Diabetes caused 416,000 deaths in 2021.²²

Dr. Paul Hsu, an epidemiologist at UCLA's Fielding School of Public Health, commented on a report about diabetes deaths, saying, "Type II diabetes itself is relatively preventable, so it's even more tragic that so many deaths are occurring."

If left untreated or undiagnosed, diabetes can lead to cardiovascular disease, diabetic nephropathy (kidney failure), and retinopathy (disease of the retina).

• The number of deaths from type II diabetes in people under 65 is rising, along with severe complications like amputations and hospitalizations in 2021.²³
• In 2020, the death rate from diabetes for adults aged 65 and older was 553.4 per 100,000 people.²⁶

• In 2019, diabetes (excluding diabetes-related kidney diseases) caused:
  • 284,049 deaths overall.³⁰
  • 139,651 deaths in men.³⁰
  • 144,398 deaths in women.³⁰
• The age-standardized death rate was 20.9 per 100,000 people. This rate varied by country, from a high of 82.6 per 100,000 in Guyana to a low of 7.2 per 100,000 in Canada.³⁰
• In 2019, diabetes mellitus caused:
  • 7.2 million years of life with disability, or 711.8 YLDs per 100,000 people.³⁰
  • The crude YLD rate nearly doubled from 376.0 per 100,000 in 2000 to 711.8 per 100,000 in 2019.³⁰
  • Age-standardized YLD rates increased from 404.2 per 100,000 in 2000 to 582.2 per 100,000 in 2019.³⁰
• In 2021, diabetes death rates were 2.2 times higher in remote areas compared to major cities. This difference was more noticeable among females (2.7 times higher) than males (1.8 times higher).³²
• Diabetes death rates rose with higher levels of socioeconomic disadvantage. After adjusting for age, people in the poorest areas had rates 2.4 times higher than those in the richest areas. This gap was slightly larger for women (2.5 times more) than for men (2.2 times more).³²

Another more pressing issue is the connection between diabetes and obesity. Several studies have found that excess weight increases the risk of developing type II diabetes.

We pulled some stats from research papers and reports to see the true extent of this correlation. 

Diabetes and Obesity Statistics

According to Sadaf Farooqi from the University of Cambridge, “There is a clear correlation between gaining weight and increased risk of type 2 diabetes, even if you don’t get it right now.” 

• Major factors responsible for the rise of type II diabetes:
  • Urbanization can impact diabetes prevalence by increasing the time people spend in sedentary activities and by encouraging higher consumption of animal products, high-fat foods, and highly processed foods.
  • An aging population
  • Low physical activity
  • Being overweight and obese ¹³
• The incidence of obesity, found to be increasing over recent decades, correlates with an increasing rate of type II diabetes. In 2013, over one-third of American adults were obese, and over two-thirds were overweight or obese.¹⁴
• Diabetes was the seventh leading underlying cause of death in the U.S. in 2021,  directly attributed to more than 103,294 deaths.³
• A total of 399,401 death certificates for 2021 mention diabetes as the underlying cause of death.³
• Other factors that place one at risk of type II diabetes include being overweight or obese, over 45 years of age, having a parent, brother, or sister with type II diabetes, exercising less than three times a week, or having a history of gestational diabetes.²³
• The National Diabetes Prevention Program says people with prediabetes can cut their risk of getting type II diabetes almost in half (58% [or 71% if over 60]) by losing just 5 to 7% of their body weight.²³
• The prevalence of obesity in type II diabetes is also on a significantly higher rise, increasing from 34% to 41% among the National Health and Nutrition Examination Survey participants.²³
• In the MESA study, obese individuals were nearly three times as likely to develop type II diabetes than were non-obese counterparts (20% versus 7.3%).²³
• In both the MESA and NHANES groups:
  • Obesity was associated with type II diabetes in 30-53% of cases.²³
  • More obese participants had a yearly family income below $50,000 and were more often non-Hispanic Black or Mexican American.²³
  • Obesity rates were lowest among non-Hispanic white females, but this group had the highest rates of obesity-related type II diabetes.²³
• Programs like the Diabetes Prevention Program clinical trial have shown that intensive lifestyle changes can lower the risk of developing type II diabetes by 58% in overweight or obese adults with prediabetes.²⁵
• According to the Gallup-Healthways Well-Being Index, obese adults aged 25 to 64 are at least four times more likely to be diagnosed with diabetes than adults of average weight.²⁷
• By their mid-to-late 30s, 9.3% of obese adults have diabetes, compared to 1.8% of those with an average weight.²⁷
• In 2016, 28.4% of U.S. adults were obese, and 11.6% had been diagnosed with diabetes.²⁷
• The highest risk for diabetes is between ages 35 and 39. During this time, obese individuals are over five times more likely to be diagnosed with diabetes compared to those with average weight.²⁷

• Obese women tend to have diabetes more than obese men until the age of 60, and after that, both categories are affected by an equal percentage.²⁷
• Those with obesity are four times more likely to be diagnosed with diabetes compared with normal-weight individuals in mid to late 20s.²⁷
• Unplanned absences due to obesity and related chronic conditions cost $153 billion in the U.S. economy every year. This is a more significant impact, considering that diabetes due to obesity is quite vital for an adult in their prime working years.²⁷

Cardiovascular disease, hypertension, and dyslipidemia (when the levels of fats in your blood are off balance, which can lead to heart disease or stroke) are obesity-related complications that complicate diabetes management.

However, according to Physiologist Lindo Bacon, it’s also important to note that “there are a lot of people in that category called obese [who] don’t have any signs of disease and live long healthy lives.” 

Diabetes Market Statistics

A growing prevalence of diabetes across the globe has turned the diabetes market into one of the rapidly developing segments within the health industry.

• The World Health Organization reports that about 1.5 million people died from diabetes in 2019.²⁴
• In 2021, global healthcare spending on diabetes was nearly $966 billion.²⁴
• In 2021, the United States spent about $11,779 per diabetes patient. This makes diabetes treatment a significant part of the pharmaceutical market.²⁴
• In 2022, Lantus, a long-acting insulin for diabetes, was Sanofi's second top-selling drug, bringing in nearly €2.3 billion in revenue.²⁴

• In 2022, North America led the type II diabetes market, holding a 35% share of the revenue.²⁸
• The global Diabetes Care Devices market is projected to reach $29.41 billion by 2024. It is expected to grow at an annual rate of 12.22%, reaching $52.34 billion by 2029.³¹
• Globally, the United States is expected to lead in diabetes care revenue, generating $11.71 billion in 2024.³¹

Big pharma companies such as Eli Lilly, Novo Nordisk, and Sanofi have implemented large-scale investments to develop next-generation insulin analogs, non-insulin medicines, and digital health solutions.

Risk Factors for Diabetes-Related Complications

Factors that may increase the risk of diabetes include:

• Being overweight or obese significantly increases the risk.
  • 89.8% are overweight or obese in the U.S. (BMI ≥ 25 kg/m²).¹⁰
  • 26.9% are overweight in the U.S. (BMI 25.0-29.9 kg/m²).¹⁰
  • 47.1% have obesity in the U.S. (BMI 30.0-39.9 kg/m²).¹⁰
  • 15.7% have extreme obesity in the U.S. (BMI ≥ 40.0 kg/m²).¹⁰
• Carrying visceral fat primarily in the abdomen—as opposed to the hips and thighs—increases the risk. Men with a waist circumference above 40 inches (101.6 cm) and women above 35 inches (88.9 cm) face higher risks.¹⁶
• Less physical activity heightens the risk. Exercise helps manage weight, utilizes gucose for energy, and enhances insulin sensitivity.¹⁶
• 31.9% are physically inactive, engaging in less than 10 minutes per week of vigorous activity across work, leisure, and transportation.¹⁰
• Having a parent or sibling with type II diabetes raises an individual's risk.¹⁶
• People of particular races and ethnicities, including Black, Hispanic, Native American, Asian, and Pacific Islanders, are more prone to developing type II diabetes compared to white individuals.¹⁶
• Increased risk is linked with low levels of high-density lipoprotein (HDL), the "good" cholesterol, and high levels of triglycerides.¹⁶
  • 39.5% have a non-HDL level ≥ 130 mg/dL.¹⁰
  • 19.9% have non-HDL levels of 130-159 mg/dL.¹⁰
  • 11.5% have non-HDL levels of 160-189 mg/dL.¹⁰
  • 8.0% have non-HDL levels ≥ 190 mg/dL.¹⁰
• The likelihood of developing type II diabetes grows with age, particularly after 35 years.¹⁶
• Prediabetes can progress to type II diabetes if not addressed.¹⁶
• Individuals who had gestational diabetes or gave birth to a baby weighing more than 9 pounds (4 kg) are at higher risk.¹⁶
• Polycystic Ovary Syndrome, marked by irregular menstrual periods, excess hair growth, and obesity, can increase the risk of diabetes.¹⁶
• 22.1% in the U.S. use tobacco based on self-reports or serum cotinine levels. ¹⁰
• 14.6% in the U.S. are current cigarette smokers.¹⁰
• 36.0% in the U.S. are former smokers, having smoked at least 100 cigarettes in their lifetime.¹⁰
• 47.4% have an A1C value of 7.0% or higher.¹⁰
• 22.9% have an A1C value of 7.0%-7.9%.¹⁰
• 11.5% have an A1C value of 8.0%-9.0%.¹⁰
• 13.0% have an A1C value above 9.0%.¹⁰
• 10.4% of adults aged 18-44 have Ha1c levels of 10% or higher, compared to 9.4% of those aged 45-64 and 2.6% of those aged 65 and older.¹⁰
• 80.6% have systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 80 mmHg, or are on medication for high blood pressure.¹⁰
• 70.8% have systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or are on medication for high blood pressure.¹⁰
• Adults with type II diabetes are twice as likely to have a heart attack or stroke compared to those without diabetes.²³

Future Projections of Diabetes Statistics

Current literature and trends can help us identify future patterns in diabetes and related health conditions. As the final section of our report, we’ve sourced some stats to provide more insight into what the future of diabetes holds. 

• Global access to technology for automated glucose monitoring and insulin delivery could save another 673,000 lives by 2040.⁹
• Universal access to insulin, test strips, and practical self-management tools could increase this number by 1.98 million by 2040.⁹
• Currently, an estimated 537 million people worldwide have diabetes. By 2045, this number is expected to rise to about 783 million.²⁴
• Between 2015 and 2030, the IAF Diabetes Model predicts that the number of people with type I and type II diabetes will rise by 19,629,000, reaching 54,913,000 people—a 54% increase.²⁵
• Comparing the new Diabetes 2030 Model to IAF's previous Diabetes 2025 Model shows that there will be 1,966,700 fewer people, or 4.5% less, with diagnosed diabetes in 2030.²⁵
• In the new model, there will be 1,519,800 (10.3%) fewer people with undiagnosed diabetes due to lower prevalence rates. As a result, the total number of diabetes cases is projected to be 3,426,500 (5.8%) lower using the Diabetes 2030 Model.²⁵
• In this model, prediabetes is more common, with an additional 12,581,900 people (a 13.2% increase) expected to have prediabetes by 2030.²⁵
• The NCBI research team predicts that the number of Americans with prediabetes will rise from 90.6 million in 2015 to 107.7 million in 2030. This means 30% of all Americans and 51% of seniors would have prediabetes.²⁵
• Researchers from the CDC estimate that one in three Americans born in 2000 will develop diabetes in their lifetime. They also predict that the percentage of Americans with diabetes will at least double by 2050.²⁷
• Over 29 million people in North America have diabetes, and this number is expected to reach 32 million by 2025.²⁸
• The number of adults with the disease is expected to rise to 700.1 million, or 10.9% of the global population, by 2045.²⁹
• North America and the Middle East have the most adults with the disease. By 2045, South Asia, where diabetes is rapidly increasing, is expected to nearly match the rates in Western Asia and Latin America.²⁹

Future diabetes care is promising because of the tremendous technological and personalized medicine advancements. 

For a more indepth look, the National Centre for Biotechnology Information has published a review of those advances.³³

The research journey in this industry will open new treatments and preventive approaches to make managing diabetes much more effortless and reduce its impact on life. 

If you are interested in a full-body checkup, book a scan with us today.  

Frequently Asked Questions

Sources

1. BMC Publich Health
2. CDC
3. American Diabetes Association
4. BMC Publich Health
5. National Library of Medicine
6. National Library of Medicine
7. Diabetes Research Institute Foundation
8. Mayo Clinic
9. Type 1 Diabetes Index
10. CDC
11. Cleveland Clinic
12. WHO
13. International Diabetes Federation
14. Medical News Today
15. International Diabetes Federation
16. Mayo Clinic
17. CDC
18. National Institute of Diabetes and Digestive and Kidney Diseases
19. BMC Pregnancy and Childbirth
20. CDC
21. Johns Hopkins Medicine
22. International Diabetes Federation
23. American Heart Association
24. Statista
25. National Centre for Biotechnology Information
26. CDC
27. Gallup
28. Precedence Research
29. World Economic Forum
30. Pan American Health Organization
31. Statista
32. Australian Institute of Health and Welfare
33. National Centre for Biotechnology Information

Cardiovascular Diseases (CVDs) include conditions like heart attacks, strokes, atherosclerosis (where arteries harden and narrow), ischemic heart disease, high blood pressure, and cardiomyopathies (diseases of the heart muscle).

According to Dr. Marta Farrero, head of the Heart Failure Unit at the Hospital Clínic Barcelona,

While Dr. Farrero's insights about older people being more affected by heart disease are accurate, it is also important to realize that preventative measures should be taken early in life. 

Dr. Laurence S. Sperling, a leading expert in preventive cardiology, was asked about preventative measures and their importance. He explained that "all cardiologists—regardless of whether they are an electrophysiologist, heart failure specialist, or adult congenital specialist—should focus on prevention. It should be part of their work. There will be a greater need for people with subspecialty training in preventive cardiology.”

Dr Sperling’s comments predict a future where specialists work more collaboratively, using advanced therapies to tackle heart disease even before it develops. The field is clearly moving towards a more holistic and proactive approach, aiming to keep people healthier longer.

We’ve compiled a list of statistics and trends about cardiovascular diseases to help you understand their scope better. 

Cardiovascular Disease Death Toll Statistics

The World Heart Federation (WHF) published a report that showed that deaths from heart disease increased worldwide from 12.1 million in 1990 to 20.5 million in 2021.¹³ 

Professor Fausto Pinto, co-author of the report and former WHF President, said, " The data doesn’t lie. This report confirms the serious threat that cardiovascular disease poses all over the world, particularly in low—and middle-income countries.”

He went on to add that:

Another significant statistic is that cardiovascular diseases (CVDs) are the leading cause of death globally. In 2019 alone, more than 6 million people aged between 30 and 70 years died from CVDs.¹⁴

So, why is this the case in today's world?

First, our lifestyles have changed dramatically. Many of us lead sedentary lives, spending hours sitting at desks or on couches, which can negatively impact our heart health.

Stress levels like cortisol also run through the roof. Juggling work, family, and social commitments can lead to chronic stress, which has been linked to heart disease. Additionally, smoking and alcohol consumption remain significant contributors to heart problems.

Healthcare access and quality vary widely around the globe. In many places, people lack access to regular checkups, early diagnosis, and effective treatment for heart conditions. This delay in diagnosis and treatment can lead to bad health outcomes.

It’s clear that the death toll due to cardiovascular disease has risen over the years, and prevention is a key measure most specialists are focusing on. We sourced some statistics to provide a holistic overview of the situation and what can be done.  

• Eating a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, working out daily, and not smoking can prevent 80% of early deaths (i.e., before age 60).³
• CVD comprises heart diseases and strokes, which are the leading causes of people being ill and dying across the whole world. Every year, 17 million deaths occur due to it, meaning it accounts for 31% of all deaths across the globe.³
• Heart diseases killed 14 million people globally in 2000. This number increased to almost 18 million in 2019 due to population growth and increased cardiovascular disease.^4,6
• CVD was one of the most significant factors contributing to people’s death in the US in 2020, and the overall death toll stood at 928,741.⁵
• More than half of the deaths from CVDs occur in young people under the age of 65.³ 
• The figures estimate that early deaths occurring in workers aged between 35 and 64 years will rise by 41% by the year 2030.³
• Heart disease and stroke kill 215 people each day in South Africa.³

• More than three-quarters of deaths from cardiovascular diseases happen in low- and middle-income countries.^6,11
• Out of the 17 million people under the age of 70 who died in 2019, 38% of them had CVDs as the cause of death.⁶
• In 2021, these diseases caused an estimated 20.5 million deaths.⁷

• Coronary heart disease causes the deaths of around nine million people every year.⁷
• Approximately 1 in 6 deaths worldwide are due to coronary heart disease.⁷
• In 2019, stroke was the world's second leading cause of death, resulting in approximately 6.6 million fatalities.⁷
• Stroke causes 1 in 9 deaths worldwide.⁷
• Globally, congenital heart disease is the direct cause of at least 220,000 deaths each year.⁷
• CVD is the leading cause of death in Australia, accounting for about 24% of all deaths. On average, around 120 people in Australia die from CVD each day, which is about one person every 12 minutes.⁸

The statistics provide interesting insights into CVD death. While it primarily targets older people (as Dr. Marta Farrero confirmed), it’s important to see how younger people can also be affected. 

In an interview about sudden cardiac deaths in athletes, Dr. Peter Yan had this to say, “For young athletes below the age of 35, a common cause of sudden cardiac death is not heart attack but congenital, inherited conditions, the commonest being hypertrophic cardiomyopathy. This is a condition where there is thickening of the muscles of the heart and also resultant fibrosis of the muscles of the heart, i.e., scarring of the heart.”  

This proves that even seemingly healthy individuals could suffer the adverse effects of heart disease.    

Cardiovascular Disease Statistics by Demographics

We’re touching on this topic because it’s important to note that heart disease disproportionately affects racial and ethnic minorities.  

According to data from the Centers for Disease Control and Prevention, “the life expectancy of non-Hispanic/Black Americans is four years lower than that of White Americans.”  

Cedars-Sinai cardiologist Merije Chukumerije, MD, says,

• 47% of Black adults have heart disease in the U.S. compared to 36% of white adults.⁹
• Hispanic women are more than twice as likely to have diabetes compared to white women.⁹
• American Indians are three times more likely to have diabetes than white people.⁹
• Black men are 70% more likely to have heart failure than white men.⁹
• Black women are 50% more likely to have heart failure than white women.⁹
• Black adults are twice as likely as white adults to be hospitalized for heart failure. They also stay in the hospital longer and are more likely to be readmitted within 90 days.⁹
• Asian adults are less likely to have coronary artery disease than other groups. However, Asian Indian men, Filipino men, and Filipino women have a higher risk compared to white people.⁹
• Young Hispanic women who have a heart attack are at a higher risk of dying than young Hispanic men. They also have a higher risk of dying compared to young Black adults and young white adults.⁹
• Ischemic heart disease (when narrowed or blocked arteries reduce blood flow to the heart) is the top cause of early death in 146 countries for men and 98 countries for women.¹¹

In 2019, there were more women than men with heart and circulatory diseases.⁷

• Heart and circulatory diseases caused the deaths of 9.8 million men and 9.2 million women in 2019.⁷
• It is estimated that 200 million people in the world have coronary heart disease.⁷
• Fifty-six million women and 45 million men have survived strokes.⁷
• At least 64 million people worldwide are estimated to have heart failure.⁷
• 1.2 million babies are diagnosed with congenital heart disease each year, which averages to 3,300 babies per day, or one diagnosis every 26 seconds.⁷
• Someone is hospitalized for heart disease almost every minute.⁸

Statistics on the Risk Factors for Cardiovascular Disease

High blood pressure or hypertension is the largest contributor to heart disease compared to other factors.³

Cardiologist Dr. Pavel Poláček says, “Untreated high blood pressure accelerates the rate of atherosclerosis (buildup of plaque and hardening of the arteries), damaging the heart muscle, kidneys, and possibly the brain.” 

He also reiterated the points that other experts have made about prevention, stating,

• Every year, there are about 6 million dead around the world due to smoking itself or passive smoking. Smoking is CVD's second-biggest reason after high blood pressure.³
• No level of exposure to secondhand smoke is safe. Non-smokers exposed to secondhand smoke have a 25–30% greater risk of developing CVD. Secondhand smoke has a toll of 600,000 deaths annually worldwide. Children account for 28% of the fatalities. CVD accounts for over 80% of adult deaths from secondhand smoke.³
• More than 80% of deaths from heart and circulatory diseases are related to modifiable risk factors.⁷

• Black women are twice as likely as white women to develop high blood pressure during pregnancy, raising their future risk of heart disease.⁹
• In a study of suburban residents aged 18 to 76, the rates of heart disease risk factors were 31.9% overweight/obese, 6.1% diabetes, 33.6% high blood pressure, 30.3% elevated apoB levels, and 11.6% metabolic syndrome.¹²
• Nutrition plays a crucial role in significantly reducing cardiovascular risk factors and lowering the risk of developing CVD.¹⁴

One of the most extensive prospective cohort studies on the Mediterranean diet in women was the Nurse’s Health Study (NHS) in the United States, which followed over 74,000 women aged 30 to 55 for 20 years.¹⁴

• It was found that sticking closely to the Mediterranean diet was linked to a 29% lower risk of coronary heart disease.¹⁴
• From these studies, the risk of CVD decreased by 19% in women and by 17% in men.¹⁴

Statistics on the Cost of Cardiovascular Disease

Heart disease and its risk factors account for a significant share of global healthcare costs.

According to the American Heart Association, that cost will triple by 2050 if not controlled, particularly factoring in growth in the American population's aging, increase in diversity, and continued high rates of factors like high blood pressure and obesity.

• Between 2018 and 2019, the total cost of CVD was $407.3 billion. This included $251.4 billion in direct medical expenses and $155.9 billion in lost productivity and mortality.⁵
• Each year, about $5 billion is spent on public hospital services for people with CVD. This makes up 11% of all hospital admission costs, the largest share for any disease group.⁸
• According to Health Canada, CVD accounted for 11.6% of the total healthcare costs in Canada that can be categorized by diagnosis.¹⁰
• CVD was the most expensive disease in Canada, costing $21.2 billion in total. This includes both direct and indirect costs. Musculoskeletal diseases came next at $18.8 billion, and cancer followed at $16.3 billion. Of the $7.8 billion spent directly on CVD, 61% was for hospital stays, 26% for medications, and 12% for doctor visits.¹⁰
• In 2006, the American Heart Association reported that the total cost of CVD in the USA was $457.4 billion. Of this, $292.3 billion (64%) were direct costs.¹⁰
• The share of indirect costs in the total cost of CVD differed between Canada and the USA (11% in Canada and 63% in the USA). However, 75% of these indirect costs in both countries were due to lost productivity from early deaths.¹⁰
• Two other studies in the USA, using claims databases or population health surveys, found that hospitalization costs comprised about 40% of the total direct medical costs for CVD. Physician costs accounted for roughly 13% to 15% of these total costs.¹⁰
• In another study of working women, drug costs made up 16% of the direct medical costs, which is close to the American Heart Association's estimate. A higher percentage of drug costs (32.8%) was seen in a Medicaid dataset.¹⁰
• Cardiovascular disease made up 12% of Europe's total healthcare spending in 2006.¹⁰

• 38% of the total cost of cardiovascular disease in Europe came from indirect costs like lost work time (21% of the total cost) and unofficial care (17%).¹⁰
• It was found that stroke prices made up 2.7% of all Ontario healthcare costs. This information came from both public and private sources.¹⁰
• Acute care hospitals were the most expensive place to get care, accounting for 49.7% of all medical costs. After that came the costs of rehab hospitals (12.5%), private care facilities (11.3%), medical services (10.1%), and home care (9%).¹⁰
• Only 1.6% of the direct medical costs of treating a stroke were for drugs and doctors' fees. ¹⁰
• Disability costs ($121.2 million) and early death costs ($279.6 million) made up 38.3% of all the costs of strokes in Ontario.¹⁰
• The initial hospitalization and follow-up costs were quite different for each type of stroke.  
  • For hemorrhagic strokes, 23% of the costs were for initial hospitalization and 77% for follow-up. ¹⁰
  • For ischemic strokes, 36% of the costs were for initial hospitalization and 64% for follow-up. ¹⁰ 
  • For transient ischemic attacks, 9% of the costs were for initial hospitalization and 91% for follow-up. ¹⁰
• Caregiver costs were part of these follow-up costs. They made up 27% of the total one-year follow-up costs for transient ischemic attacks ($17,769), 12% of the total costs for ischemic strokes ($53,576), and 11% of the total costs for hemorrhagic strokes ($56,573).¹⁰
• The direct medical costs of hypertension are made up of drug costs (51.2%), hospitalization costs (23.5%), and healthcare professional visit costs (20.4%).¹⁰
• From the viewpoint of a USA employer, the yearly cost of hypertension per employee was estimated to be $150, with $99 of that amount spent on medication.¹⁰
• In Italy, a study by Berto et al. found that the biggest part (46%) of the medical costs for treating high blood pressure came from medications. Visits to general practitioners comprised 21% of the costs; hospital stays 15%, and lab tests 13%.¹⁰
• A large managed care claims database study found that the six-month healthcare cost for CHF in the USA is $3,283 per patient.¹⁰
• In comparison, the yearly cost per patient with CHF was found to be $3,802, based on a state Medicaid dataset analysis.¹⁰
• A Markov model estimated that treating 616,900 new annual cases of coronary artery disease (CAD) in the USA would cost $9 billion in the first year, $15 billion over five years, and $20.5 billion over ten years.¹⁰
• The yearly medical costs for CAD in the USA were $53.7 billion when CAD was the primary diagnosis and $121.9 billion when CAD was listed anywhere in the diagnosis, according to different public and private databases in the USA.¹⁰
• In a look back at a managed care database, hospital stays and drug costs made up 72% and 7% of the two-year medical expenses for patients with newly diagnosed acute coronary syndrome (ACS).¹⁰
• Using detailed patient information and modeling methods, Eisenstein et al. found that about 50% of the medical costs for ACS happen during the acute phase (the initial period after the condition occurs).¹⁰

CVD and stroke are significant contributors to healthcare costs worldwide, including large-scale direct medical outlays and indirect costs from lost productivity. Findings show that inpatient care, medications, and follow-up care mainly contribute to direct costs. 

Global Cardiovascular Disease Statistics

Cardiovascular diseases are prevalent in every part of the world, but the highest mortality rate is reported in countries located in Asia, Europe, Africa, and the Middle East. Major causal factors include high systolic blood pressure, high ApoB levels, unhealthy food, and air pollution.

Gregory A. Roth, MD, MPH, senior author of the paper, associate professor in the Division of Cardiology, and director of the Program in Cardiovascular Health Metrics at the Institute for Health Metrics and Evaluation at the University of Washington, said,

• 2% of deaths from heart diseases are caused by rheumatic heart disease.⁶
• Around 620 million people worldwide have heart and circulatory diseases. This number is increasing because of changing lifestyles, an aging and growing population, and better survival rates from heart attacks and strokes. If these trends continue, the number will keep rising.⁷
• Every year, about 60 million people worldwide get a heart or circulatory disease.⁷

• It is estimated that at least 13 million people around the world have congenital heart disease, a condition present at birth that affects the structure and function of the heart; there might be millions more who have not yet been diagnosed.⁷
• One in 6 people in Australia say they have cardiovascular disease, which is more than 4.5 million people^.8
• In 2019, the North Africa and Middle East regions had the second-highest death rates. For men, it was 376.7 per 100,000 people, and for women, it was 339.8 per 100,000.¹¹
• Ischemic heart disease is the top cause of CVD deaths globally, except for women in Sub-Saharan Africa.¹¹ 
• In 2019, the death rate for cardiomyopathy (any disorder that affects the heart muscle) and myocarditis (inflammation of the heart muscle) in men was over three times higher in Central and Eastern Europe and Central Asia (28.5 per 100,000) than in Sub-Saharan Africa (8.4 per 100,000) and thirty times higher than in South Asia (0.8 per 100,000).¹¹
• In 2019, nearly a third of the countries (six out of 21) in the North Africa and Middle East region had more women dying from heart disease than men.¹¹
• Significant differences were found in Qatar (464.6 deaths per 100,000 women compared to 301.9 per 100,000 men), Egypt (600.0 per 100,000 women compared to 491.6 per 100,000 men), and Algeria (447.7 per 100,000 women compared to 371.5 per 100,000 men).¹¹
• Likewise, in 13 out of 46 countries in Sub-Saharan Africa, women had higher death rates from CVDs than men.¹¹

CVDs are among the world's leading killers and worsen due to lifestyle and demographic transitions. Peter Attia, MD (Founder of Early Medical) made a valid point when he said that early interventions and aggressive treatment of apoB levels could prevent plaque buildup in arteries.

He added that this disease often starts at a young age; therefore, management must be comprehensive, involving medication, diet, and lifestyle.

We hope you found our statistics helpful. If you are interested in a full-body checkup, book a scan with us today.

Frequently Asked Questions

Sources

1. Cardiovascular diseases (CVDs)
2. Frequently Asked Questions About Heart Disease
3. Cardiovascular Disease Statistics Reference Document
4. Cardiovascular Diseases
5. Heart Disease and Stroke Statistics
6. Cardiovascular diseases (CVDs)
7. Global Heart & Circulatory Diseases Fact Sheet
8. Statistics and information on cardiovascular disease in Australia
9. How Race and Ethnicity Impact Heart Disease
10. A review of the cost of cardiovascular disease
11. The Heart of the World
12. Prevalence of risk factors for cardiovascular disease
13. Deaths From Cardiovascular Diseases
14. National Library of Medicine
15. Cardiovascular disease costs by 2050
16. Cardiovascular Disease

Fear of medical examinations is widespread and affects many people, from childhood to adulthood. Procedures such as breast cancer or prostate screenings, blood tests, or MRI scans can trigger anxiety for various reasons. Two main concerns are at the forefront: the fear of a serious diagnosis and the worry about possible discomfort or pain during the examination. Magnetic Resonance Imaging (MRI) is no exception, and many patients experience similar fears. A British survey found that 25% of respondents would refuse medical treatment due to their intense fear of the MRI scan. According to a study by Berlin's Charité, between 1 and 15% of patients miss pre-scheduled MRI appointments. A German thesis even documented a 39% dropout rate for MRI scans.

Despite these figures, MRI is an extremely safe, non-invasive, and highly effective method for detecting a wide range of conditions in their early stages, when they are still easily treatable. Unlike other imaging methods, MRI involves no radiation exposure since images are generated using a strong magnetic field and RF pulses. In many cases, contrast agents are not needed, and as long as there are no metal objects in the body, the process is straightforward: the patient lies on a table that slides into the MRI scanner, the images are taken, and the scan is completed within 15 to 60 minutes.

So why are there so many cancellations and concerns about MRI scans?

MRI and Claustrophobia

The most common reason for discomfort during MRI scans is claustrophobia. In the confined space of the MRI machine, patients must remain still while hearing knocking noises.

According to a study by Charité, about 35% of MRI patients experience claustrophobic symptoms, even though only 2.3% are diagnosed with actual claustrophobia. These symptoms typically manifest as discomfort. However, even in such cases, there is no need to worry, as patients can communicate with medical staff at any time via a speaker system and emergency button.

Fear of MRI Results

A common cause of anxiety related to MRI scans is the fear of a bad diagnosis. The thought that the scan could reveal a serious condition, such as cancer, can be terrifying. However, it is important to understand that early detection dramatically improves survival rates. For cancers like colorectal or lung cancer, survival rates in the early stages can be as high as 90%, while they drop significantly in later stages. This is supported by a study from the American Cancer Society, which shows that the 5-year survival rate for stage I colorectal cancer is 91%, while it drops to only 14% at stage IV. Similarly, lung cancer survival rates in early stages are about 60%, but fall to around 6% in later stages, according to a study by the National Cancer Institute.

Another related fear is not knowing what happens once an abnormality is found. If Aeon detects something during your MRI, we’ll guide you further. We work with a network of experienced specialists to whom we can refer you if needed, whether it's for further diagnosis, specific treatments, or a second opinion. Your well-being is our top priority, and we support you every step of the way.

Fear of Misdiagnosis

Another common concern related to MRI scans is the fear of misdiagnosis—either a false result leading to unnecessary treatments or a serious condition being missed. In rare cases, false-positive or false-negative results can occur. A false-positive means something is flagged as problematic but turns out to be harmless, while a false-negative misses an existing condition.

At Aeon, we minimize these risks by validating MRI results with our precise blood analyses. This cross-validation significantly reduces the likelihood of false-positive results by complementing imaging with biochemical markers. By combining MRI scans with blood tests, we ensure that you get a particularly accurate and comprehensive picture of your health. Unclear results are usually followed up with additional tests to further reduce the risk of misdiagnosis. If you want to learn more about false-positive diagnoses, you can find further information here.

How Can You Manage Fear of MRI Scans?

If you're feeling anxious due to claustrophobia or fear of bad results, there are various strategies and alternatives that can help:

• Larger MRI Machines: Newer MRI machines have larger diameters, which significantly reduce claustrophobia. Check if radiology centers near you offer these machines. At Aeon, for example, we use modern MRI systems.
• Listen to Music or Watch Videos: Many MRI machines allow you to listen to music during the scan. At Aeon, you can even play your own Spotify playlist.
• Bring a Companion: Having a trusted person with you during the scan can significantly ease anxiety.
• Practice Deep Breathing and Meditation: Breathing exercises or meditation are proven methods for managing anxiety during an MRI.
• Consider Sedation: In cases of severe anxiety, a sedative may help you relax without impairing your ability to function. At Aeon, you can choose between a milder nasal spray or stronger sedatives, which your doctor will explain beforehand.
• Use the Emergency Button: You can stop the scan at any time if the discomfort becomes overwhelming.
• Inform Yourself About the Procedure: Knowing what to expect during an MRI scan can ease many of your concerns. Watching explanatory videos can also help, as they give you a clearer idea of what to expect. Many hospitals or radiology centers offer these videos on their websites.

Are There Alternatives to a Classic MRI?

Yes, if you prefer not to undergo a traditional MRI, there are several alternatives. You can opt for a different imaging method or one of the newer forms of MRI that have been developed in recent years.

Regarding other imaging methods, please note that they do not directly replace MRI.

They provide different, often complementary information to what an MRI would deliver. Therefore, it is crucial to discuss with your doctor whether an alternative method makes sense in your specific case.

Computed Tomography (CT)

CT scans are often considered an alternative to MRI, but they offer different insights. While CT scans are faster and less noisy, they involve exposure to X-ray radiation, unlike MRI. Moreover, CT is less suitable for precise imaging of soft tissue structures, such as muscles, ligaments, and organs, which MRI excels at.

If you want to learn more about the differences between MRI and CT, you can find a detailed article here.

Nuclear Medicine

Nuclear medicine procedures, such as PET or SPECT scans, can be used in specific cases as a complement to MRI, particularly for assessing metabolic processes. These scans involve the use of radioactive substances, which are detected by a scanner. However, anatomical details, often crucial for precise diagnoses, are not as clearly depicted as with MRI. Moreover, patients are exposed to ionizing radiation during these tests, unlike with MRI.

Open MRI and Seated MRI

There are now MRI machines designed to address claustrophobia concerns. These include “open MRIs” and “seated MRIs.”

In an open MRI, you still lie on a movable table that enters a scanner, but the scanner is not a closed tube. Instead, it has several large openings. This allows you to lie slightly turned on your side or even sit upright.

A seated MRI, also known as an upright MRI, resembles a small room that opens up in width at the front. It's called upright MRI because the design allows the patient not only to sit but also to stand during the examination.

The open design of both device types helps to prevent claustrophobia and reduces the noise from the magnetic coils.

However, both open and seated MRIs have three significant disadvantages compared to a traditional MRI machine:

1. Image Quality: Due to the open structure, the magnetic fields in open MRI machines are weaker, resulting in lower image quality. This is a critical disadvantage, especially for detailed examinations of tissue structures. Our closed, state-of-the-art MRI machines provide optimal image sharpness, which is essential for an accurate diagnosis.
2. Examination Duration: Open MRI machines take longer to capture the necessary images because of the weaker magnetic fields. This leads to longer examinations, whereas our closed MRI scanners work more efficiently and deliver faster results, making the examination more comfortable and time-saving.

Conclusion

It’s completely normal to feel anxious about the confined space of an MRI machine or about the results of the scan. However, getting these results early is crucial. The sooner a diagnosis is made, the quicker treatment can begin, and the better the chances of recovery. MRIs are ideal for early disease detection due to their high image clarity, particularly when conditions are still treatable.

If you have concerns about claustrophobia, there are several strategies that can help:

• Use larger MRI machines: Modern MRI machines, like those used at Aeon, have a larger diameter, significantly reducing the feeling of confinement.
• Listen to music or watch movies: At Aeon, you have the option to listen to music or watch films during the examination to make the process more pleasant.
• Bring a companion: A trusted person can accompany you during the scan, which can greatly ease anxiety.
• Breathing exercises and meditation: These are proven methods to help you remain calm during the examination.
• Sedation: If the anxiety is too overwhelming, mild sedatives can be used. At Aeon, we offer several options, which you can discuss with your doctor beforehand.
• Emergency button: You always have the option to stop the examination if the discomfort becomes too intense.
• Be well-prepared: Inform yourself in advance about the procedure and discuss any concerns with your doctor to gain more confidence.

If you want to learn more about our MRI options or book an appointment directly, you can easily book a scan here.

Most people have had at least one X-ray in their lifetime, such as for a broken bone or at the dentist. However, a Magnetic Resonance Imaging (MRI) or a Computed Tomography (CT) scan is far less common. This often leads to uncertainty about what these terms actually mean, what these examinations are used for, and how they differ.

Our article answers these questions and offers our recommendation at the end regarding which method is best suited for diagnosing specific conditions.

What Are MRI and CT? – Similarities

MRI and CT are both imaging techniques used in radiology to diagnose diseases and injuries. Both produce cross-sectional images of the inside of your body. In both cases, a contrast agent may be used to better identify certain conditions. However, at Aeon, we avoid using contrast agents to eliminate the risk of side effects. Our MRI sequences are optimized to the point where no contrast agent is necessary.

Additionally, in both examinations, you should remain as still as possible since movement can disrupt imaging and reduce the quality of the results.

How Do MRI and CT Differ?

The two biggest differences between MRI and CT concern how they work and the associated radiation exposure for patients.

A CT scan uses X-rays to visualize the body’s interior, while MRI images are created using magnetic fields and radio waves. This means that, unlike a CT scan, there is no radiation exposure with an MRI. Below, we will go into more detail about each difference.

Procedure & Functionality

MRI

An MRI scan is a simple and painless process that typically takes between 15-60 minutes, depending on the area of the body being examined.

Since MRI uses strong magnetic fields, any metal (e.g., jewelry, piercings, etc.) must be removed before the scan. If you have any metallic implants (e.g., a pacemaker), please inform the examination team during the consultation.

During the scan, you lie on the examination table inside a tube called a scanner. While the scanner captures cross-sectional images of your body’s interior, you will hear knocking noises, caused by the gradient coils constantly turning on and off.

In an MRI, images of the body's interior are created by utilizing the hydrogen atoms within. These hydrogen atoms have protons that usually move in random directions. When a strong magnetic field is applied, these protons align in a specific direction. Radio waves are then sent to them, causing the protons to move. The device measures this movement and uses it to produce images of the body's interior.

To create accurate images, various magnetic fields acting in different directions are required. These additional magnetic fields come from special magnetic coils within the machine. These coils must constantly turn on and off and adjust themselves to capture images from different areas of the body. The frequent switching of these magnetic coils is the reason for the typical knocking noises heard during an MRI scan.

To reduce noise levels, you will be provided with hearing protection (headphones or earplugs) to dampen the sounds. At Aeon, you can even listen to music during your MRI scan. Throughout the entire scan, you can communicate with our medical experts to ensure you feel comfortable.

In most cases, you can resume your normal activities immediately after the scan. At Aeon, the images are analyzed by a Swiss radiologist, and you will receive the results within 72 hours, which you can discuss with your doctor.

CT

A CT scan is generally simple and painless, as long as no contrast agent needs to be injected. It usually takes less time than an MRI, typically between 5-15 minutes.

Unlike an MRI, metal parts do not pose a problem for a CT scan since CT scans do not use magnetic fields but instead rely on X-rays. These X-rays pass through your body and are captured by detectors on the opposite side. Both the X-ray tube and detectors rotate around the patient, taking numerous cross-sectional images of the body from different angles. A computer then assembles these into a detailed 3D image of your body’s interior.

After a CT scan, you can typically resume your normal activities immediately.

Radiation Exposure

Unlike CT scans and traditional X-rays, Magnetic Resonance Imaging (MRI) does not use ionizing radiation. As there is no risk of radiation exposure (e.g., risk of cancer), MRI is the safer option, especially for repeated use, including for children and young adults.

Application Areas

A CT scan is particularly effective for imaging bone structures. It is commonly used to assess bone fractures, calcifications, or other bone-related conditions. Additionally, it provides detailed images of the lungs, making it useful for diagnosing pulmonary embolisms, pneumonia, and lung tumors.

On the other hand, an MRI offers better soft tissue differentiation, making it ideal for imaging the spinal cord, muscles, tendons, ligaments, internal organs, and blood vessels. This is why it is highly effective for detecting changes in soft tissue, especially inflammation and tumors.

If you'd like to learn more about when an MRI is recommended, check out our detailed article here.

Contrast Agents

When contrast agents are used, different substances are employed for CT and MRI due to the differences in how the scans work.

For CT scans, iodine-based contrast agents are typically used because iodine absorbs X-rays more effectively.

For an MRI, the contrast agent usually contains gadolinium, which interacts with magnetic fields to enhance image contrast.

The use of contrast agents in both CT and MRI must be carefully considered by the attending physician. In some cases, they are essential for highlighting specific tissues or structures and providing more accurate diagnoses. However, contrast agents can also cause side effects (such as nausea and headaches) and are generally not used for pregnant patients or those with known allergies to the agent or kidney dysfunction.

For more information about the side effects of contrast agents, click here.

At Aeon, we avoid using contrast agents to eliminate the risk of side effects.

Conclusion

Whether you should undergo a CT or MRI scan for preventive care depends on several factors. A CT scan is usually faster, but an MRI allows for an examination without radiation exposure. Iodine-based contrast agents used in CT scans are more taxing on the kidneys than gadolinium in MRI scans. However, CT scans are often better suited for patients with metal implants.

Ultimately, the decision depends on what needs to be examined. As a general rule of thumb: for bones and lungs, choose CT; for muscles, soft tissues, the spine, internal organs (except lungs), and blood vessels, choose MRI.

You can book a full-body MRI check-up with us here.

According to data from the Swiss Cancer League, colorectal cancer accounts for 10% of all cancer cases, making it the third most common cancer among men and women.

It's important to know that the common term "colorectal cancer" usually refers specifically to colon cancer, meaning colon carcinoma and rectal carcinoma (medically referred to as colorectal carcinoma). This is because small intestine cancer is much rarer, accounting for less than 1% of all new cancer cases. In this article, we will focus on colon cancer.

Colorectal cancer generally develops after the age of 50, with more than half of cases being diagnosed after the age of 70. It's important to emphasize that many diseases are present long before a diagnosis is made. Although colorectal cancer is the third most common cancer, it accounts for only 10% of all annual cancer-related deaths, meaning it is not statistically one of the most aggressive tumors. The five-year survival rate across both genders after diagnosis is 69%.

A significant reason for this is that the early detection of colorectal cancer through regular screening has vastly improved. Especially when cancer is detected in Stage 1, the chances of successful treatment are very high: The five-year survival rate is over 90%.

As with all cancers, regular screening is crucial: The earlier the cancer is detected, the better and simpler the treatment will be. To help you decide how best to take preventive measures for yourself, we will provide an overview of all the important colorectal cancer screening methods.

What Screening Methods Are Available for Colorectal Cancer?

There are three standard screening methods for colorectal cancer:

• Fecal Occult Blood Test (FOBT)
• Colonoscopy

We will explore these options in more detail below.

At What Age Is Colorectal Cancer Screening Recommended?

If no factors for increased risk are present, both women and men are recommended to begin regular check-ups for colorectal cancer screening starting at age 50.

A regular check-up means either having a fecal occult blood test (FIT) every two years or a colonoscopy every ten years. For women, a colonoscopy is recommended starting at age 55, as they tend to develop colorectal cancer later than men.

Below, we will introduce the two main screening methods for colorectal cancer.

Fecal Occult Blood Test (FOBT)

This test is quick, non-invasive, and painless. A stool sample is analyzed in a laboratory for the presence of blood, which is usually not visible to the naked eye. The presence of blood may indicate cancerous growths (tumors) in the colon.

If blood is detected, it does not always indicate cancer. The blood could also be due to chronic inflammatory bowel diseases, hemorrhoids, or benign polyps in the colon. However, benign polyps are often precursors to cancer.

Therefore, a fecal occult blood test does not diagnose cancer but serves as an initial indication of potentially concerning results.

Colonoscopy

A colonoscopy involves a physician (usually a gastroenterologist) inserting a flexible tube (endoscope) with a camera into the colon. This allows for the examination of the entire colon.

There is also the option of a sigmoidoscopy, a "small colonoscopy" in which only the last 40-60 centimeters of the colon are examined. Sigmoidoscopy is shorter and less uncomfortable than a full colonoscopy, but it only detects about two-thirds of all colorectal tumors.

In both types of colonoscopy, the camera inserted into the colon transmits images to a screen, allowing your doctor to detect colorectal cancer with high accuracy. Colon polyps—benign growths of the mucous membrane—can be removed during the procedure. This is advisable because even benign polyps can turn into malignant tumors.

A colonoscopy is usually performed under sedation, meaning you are given medication and sleep during the procedure. Additionally, your colon must be completely empty to ensure that nothing obscures the images. Therefore, it is important to drink plenty of fluids the day before and on the day of the colonoscopy. The day before, you must take a laxative.

What Are the Benefits of Regular Colorectal Cancer Screenings?

Regular screenings for colorectal cancer offer several benefits:

1. Improved Treatment Options: Early detection of a tumor significantly increases the chances of successful cancer treatment.
2. Halved Mortality Rate: Since colorectal cancer can be detected and treated at an early stage, the risk of death for individuals under 80 is reduced by half, according to Swiss Cancer Screening.
3. Prevention of Colorectal Cancer: During a colonoscopy, polyps (growths) can be removed before they develop into cancer.
4. Improved Quality of Life: Advanced colorectal cancer can have severe consequences, which early detection usually prevents. With early diagnosis, additional treatments like chemotherapy may be avoided.

Overall, regular screenings greatly reduce the risk of colorectal cancer and its potential impact.

How Can I Reduce the Risk of Developing Colorectal Cancer?

You can effectively reduce your risk of colorectal cancer by making certain lifestyle choices.

While advanced age and hereditary factors (about 10-15% of colorectal cancers are hereditary) play a role, a healthy lifestyle can help protect against the development of colorectal cancer and even slow the growth of cancer cells.

A healthy lifestyle includes:

• Regular physical activity
• Avoiding alcohol consumption
• Not smoking
• Limiting processed food intake
• Maintaining a healthy weight

Additional Prevention Tips

There are various approaches to preventing colorectal cancer. Here are some important points:

• Screening and Early Detection: Regular screening, particularly starting at age 45 or earlier for those with a family history of colorectal cancer, is key. Colonoscopies are the most effective method for detecting polyps that can develop into cancer.
• Diet: A diet rich in fiber helps reduce the risk of colorectal cancer. Incorporating plenty of fruits, vegetables, and whole grains is recommended. Anti-inflammatory diets, such as the Mediterranean diet, which is rich in vegetables and low in processed foods, are especially beneficial.
• Anti-inflammatory Measures: Chronic inflammation can increase the risk of cancer. Taking anti-inflammatory medications, such as aspirin, in consultation with a doctor, can be a preventive approach.
• Microbiome Health: A healthy and diverse microbiome may reduce cancer risk. A diet rich in prebiotics and probiotics (e.g., fermented foods) can support good gut bacteria.
• Genetic Testing: For those with a family history of colorectal cancer or known genetic mutations, genetic testing and counseling can help assess individual risk and recommend appropriate preventive measures.

Aside from lifestyle changes, regular screening remains the most effective way to prevent colorectal cancer.

In most Swiss cantons, colorectal cancer screening is covered by insurance starting at age 50 (age 55 for women), with earlier screenings available for those with a family history. The costs for a fecal occult blood test (every two years) and colonoscopy (every ten years) are covered by the Swiss Mandatory Health Insurance (OKP), including the co-pay, while the annual deductible does not apply.

By combining these strategies, you can significantly reduce your risk of colorectal cancer while promoting overall health.

Conclusion

As the third most common cancer, colorectal cancer has a high survival rate primarily because it can be treated and even cured when detected early.

This makes regular screenings essential.

A colonoscopy can actively prevent tumor development by removing polyps. Additionally, a healthy lifestyle significantly reduces the risk of developing colorectal cancer in the first place.

Most importantly, you should take advantage of early detection screenings and sign up for your canton’s colorectal cancer screening program.

If you're interested in a full-body check-up, feel free to schedule a free consultation with us.

Statistically, one in five people in Switzerland is diagnosed with cancer before the age of 70. With approximately 43,000 new cases and 17,000 deaths per year, cancer is the second leading cause of death in the country, after cardiovascular diseases. Among men aged 45 to 84 and women aged 25 to 84, cancer is even the leading cause of death.

However, there has been progress: Compared to 2017, cancer mortality has decreased, and cancer patients now have a higher life expectancy on average.

The following data is largely sourced from the Cancer Report 2021, which is published every five years by the Federal Statistical Office (BFS), the National Cancer Registry (NKRS), and the Childhood Cancer Registry (KiKR).

How does cancer develop? -> Info Box

Cancer develops when the genetic material (DNA) of a single cell changes. This change can be caused by various factors, such as genetic predisposition or external influences (e.g., pollutants, radiation). This alteration of the DNA leads to disruptions in normal cell functions, which results in uncontrolled cell growth and the formation of a tumor. The tumor can grow locally, invade surrounding tissues (infiltration), and form metastases, i.e., secondary tumors in other organs of the body.

Increase in New Cancer Cases in Switzerland

Between 2013 and 2017, an average of 23,100 new cancer cases in men and 19,650 new cancer cases in women were diagnosed annually in Switzerland. This represents an 8.5% increase compared to the period from 2008-2012. For the year 2021, researchers estimated 48,300 new cases, which could lead to another increase by 2024.

Over a four-year period (2016-2020), cancer incidence, i.e., the number of new cases per year in Switzerland, was 25,000 in men (55%) and 20,000 in women (45%). Thus, men are more likely to develop cancer than women.

According to the Cancer League, the four most common types of cancer in Switzerland are:

• Prostate cancer: The most common cancer in men, accounting for about 30% of all male cancer cases.
• Lung cancer: The second most common cancer in both men and women, accounting for about 11% of all new cases in men and 10% in women.
• Breast cancer: The most common cancer in women, making up 32% of all female cancer cases.
• Colorectal cancer: The second most common cancer in women, accounting for about 10% of all female cancer cases. In men, 10% of all cancers also affect the colon.

Relationship Between Age and Cancer Prevalence

The main risk factor for developing cancer is age. Most new cancer cases occur in older age, with the risk varying between men and women. The median age at first diagnosis for cancer patients is 66 years.

However, cancer prevalence changes with age. While children and adolescents are more often affected by leukemia or brain tumors, colorectal cancer, prostate cancer, and breast cancer are more common in adulthood.

Significant Differences in Cancer Survival Rates

Survival chances after a cancer diagnosis vary greatly depending on the type of cancer. Testicular cancer, melanoma, Hodgkin lymphoma, prostate cancer, thyroid cancer, breast cancer, and lymphatic leukemia have the highest five-year survival rates, exceeding 80%.

In contrast, the five-year survival rate for patients with tumors of the pancreas, lung, gallbladder and bile ducts, and liver is below 30%.

The improved survival rates lead to a rising cancer prevalence, meaning that more and more people are living longer with the disease. Between 2006 and 2016, the number of cancer patients living for ten years or more after diagnosis increased from approximately 163,450 to around 210,350.

Highest Mortality Rate in Lung Cancer

Lung cancer, with 3,235 deaths per year, is the leading cause of cancer-related death for both men and women. This is despite the fact that lung cancer mortality has significantly decreased in recent years.

Most Common Cancer-Related Deaths:

Men:

• Lung cancer (21%)
• Prostate cancer (14%)
• Colorectal cancer (10%)

Women:

• Breast cancer (18%)
• Lung cancer (18%)
• Colorectal cancer (10%)

Decline in Mortality for Many Cancers

Over the past 30 years, age-standardized cancer mortality rates have decreased significantly:

• Men: -39%
• Women: -28%

This decline is observed across most types of cancer.

For prostate cancer, mortality decreased by 13% between 2013 and 2017.

There has also been a decline in mortality rates for breast cancer (-7%) and colorectal cancer (-13% in men, -7% in women) during the same period.

Increase in Mortality for Women

Early detection and advancements in cancer research generally contribute to lower death rates. However, in some cases, there has been an increase in cancer-related mortality among women:

• Slight increase in lung cancer mortality in women (+5%).
• Rising mortality rates in women for multiple myeloma, as well as liver and pancreatic cancers.

Good Survival Rates, Low Incidence and Mortality Rates

In a European comparison, Switzerland performs well in terms of cancer outcomes: Survival rates are average, while incidence and mortality rates are low.

Incidence:

• Men and Women: Compared to 9 other European countries, Switzerland has an overall low cancer incidence.
• Melanoma: An exception is melanoma, or skin cancer, which is the most dangerous form of skin cancer. Melanoma occurs above average in Switzerland, leading to a higher incidence rate.

Cancer Mortality:

• Women: In comparison to other countries, cancer mortality among women is low in Switzerland.
• Men: Six comparison countries have a lower mortality rate for men than Switzerland.

5-Year Survival Rate:

In terms of the 5-year survival rate, Switzerland ranks in the upper middle range.

Risk Factors for Cancer

The exact cause of cancer in individual cases is often difficult to determine. However, epidemiological studies show that various factors can contribute to the development of cancer. These factors can be divided into three main categories:

1. Behavioral Risk Factors:

• Smoking: Smoking is by far the most important risk factor for cancer. Tobacco smoke contains numerous carcinogens, which means it can cause cancer almost anywhere in the body. This includes cancers of the mouth, throat, esophagus, stomach, colon, rectum, liver, pancreas, larynx, lungs, trachea, bronchi, kidneys, renal pelvis, bladder, and cervix, as well as acute myeloid leukemia.
• Alcohol consumption: Excessive alcohol consumption can also increase the risk of various cancers, including liver, esophagus, colon, and breast cancer. The more alcohol a person regularly consumes over an extended period, the higher their risk of developing cancer. A French study found that in 2015, nearly 28,000 new cancer cases in France were due to alcohol consumption, accounting for 8% of new cancer cases.
• Unhealthy diet: A common myth is that red meat leads to cancer, but this is only partly true. It is often because people who eat a lot of (red) meat also tend to have an unhealthier diet. Furthermore, highly processed foods and beverages, due to their high sugar and sodium content, can lead to obesity and increase the risk of cancer.
• Lack of exercise: Physical inactivity is another risk factor for cancer. Regular exercise, on the other hand, can reduce the risk. The German Cancer Research Center refers to several studies showing that regular physical activity can lower the risk of cancer, especially colon cancer, with the protective effect being more pronounced in men than in women. Regular exercise can also reduce the risk of breast and uterine cancer (endometrial cancer). The relationship between exercise and lung cancer is not yet fully understood, and no clear link has been established between exercise and other types of cancer.
• Sun exposure: Excessive sun exposure without adequate protection can cause both non-melanoma and melanoma skin cancer. According to a report by the World Health Organization (WHO) and the International Labour Organization (ILO), sun exposure during outdoor work is a risk factor for non-melanoma skin cancer (NMSC). The study found that nearly one-third of deaths from this type of skin cancer are related to outdoor work.

2. External Environmental Risk Factors:

• Infections: Chronic infections with certain viruses and bacteria can increase the risk of various cancers. These include hepatitis B and C, Helicobacter pylori, and some types of human papillomavirus (HPV).
• Hazardous substances at work and in the environment: Exposure to certain hazardous substances at work or in the environment can increase cancer risk. These include asbestos, benzene, and radon.
• Air pollution: Air pollution can increase the risk of lung cancer. According to the WHO, 99% of the world's population is exposed to inadequate air quality. The health consequences of air pollution are similar to those of smoking, ranging from cancer to strokes and respiratory and cardiovascular diseases.

3. Individual Life History Factors:

• Genetic factors: Genetic predisposition to cancer can be inherited through a congenital mutation in the DNA. In 5 to 10% of cases, cancer occurs due to hereditary predisposition.
• Hormonal factors: Hormonal changes, such as early menarche, late menopause, or hormone replacement therapy, can increase the risk of certain cancers, such as breast and cervical cancer.
• Age: The older a person gets, the more likely they are to develop cancer. Age is actually the biggest risk factor for cancer, with more than nine out of ten cancers being diagnosed in people over 50 years old. People over 75 years of age make up about a third of all new cancer cases.
• Inflammation and autoimmune diseases: Over time, chronic inflammation can cause DNA damage and lead to cancer. People with chronic inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, have an increased risk of colorectal cancer.
• Medical treatments: Certain medical treatments, such as chemotherapy or radiation therapy, can increase the risk of secondary cancers.

Prevention: How to Reduce Cancer Risk

Cancer develops through a complex interaction of genetic and environmental factors. While genetic factors cannot be influenced, 30% of cancer cases in Switzerland can be prevented through preventive measures:

• Around 5% to 10% of all cancers are caused by inherited mutations in DNA.
• The remaining cancers arise due to carcinogens or an interaction between genetic predisposition and carcinogens.
• As a result, individual cancer risk can vary, even with the same exposure, depending on genetic susceptibility.

Prevention strategies:

• Avoiding risk factors like smoking, alcohol abuse, unhealthy diet, and lack of exercise
• Participating in vaccination programs (e.g., for HPV and hepatitis B)
• Engaging in screening programs (e.g., for breast and colorectal cancer), which can contribute to cancer prevention

In Switzerland, some cantons offer cancer screening programs focused on two of the most common types of cancer:

• Breast cancer: Early detection through mammography.
• Colorectal cancer: Early detection through a stool test and colonoscopy.

Recommendations for Cancer Prevention

The European Code Against Cancer and the World Health Organization (WHO) recommend the following measures to reduce cancer risk:

• Leading a healthy lifestyle
• Protecting against exposure to dangerous substances at work
• Getting vaccinated (HPV and hepatitis B)
• Regular participation in cancer screening
• Reducing radon exposure in indoor environments
• Promoting breastfeeding in women
• Limiting the use of hormone replacement therapies in women
• Avoiding unnecessary exposure to ionizing radiation (e.g., X-rays)
• Reducing indoor and outdoor air pollution levels

Every year in Switzerland, 17,200 people die from cancer, making it the second leading cause of death in the country. Among men, prostate cancer is the most common cancer-related cause of death (21% of cases per year), followed by lung cancer (14%) and colorectal cancer (10%).

For women, breast cancer ranks first (18%), followed by lung cancer (15%) and colorectal cancer (11%). Approximately 45,500 people are newly diagnosed with cancer in Switzerland each year.

Cancer survival rates have significantly improved over the past decades. Today, around 68% of cancer patients live five years after diagnosis. This improvement is largely due to the increasing availability of cancer prevention programs. Many cantons already offer screening programs to enable better early detection and treatment.

In the following article, we will explain what screening means, which screening programs are available, and who these programs are particularly recommended for.

What is Screening?

Screening refers to a systematic testing procedure in a person to detect diseases early before symptoms appear. The goal is to discover cancer or other diseases at a stage when they are still treatable, thus improving the chances of recovery.

The risk of developing cancer increases with age. Other factors such as family history, smoking, excessive alcohol consumption, unhealthy diet, lack of exercise, and certain viruses like HPV and Hepatitis B also play a role.

Why is Screening Important?

Screening involves testing people who have no symptoms to check for cancer or other diseases. Regular early detection exams can identify cancer at an early stage when tumors are still small and potentially easier to treat.

Early detection can potentially prevent some cancers from developing. It is believed that 93% of cervical cancer cases can be prevented through cancer screening and HPV vaccination. Studies suggest that 68% of colorectal cancer deaths can be prevented. Women who participated in mammography screening had a 41% lower risk of dying from breast cancer within the following 10 years.

Who Should Participate in Screening Programs?

The Cancer League recommends regular preventive exams for breast cancer, cervical cancer, prostate cancer, and colorectal cancer. Lung cancer screening can be considered particularly for high-risk patients.

For many other types of cancer, studies are ongoing to determine how best to detect cancer before symptoms appear.

Which Screening Tests Are Available?

Skin Cancer Screening

Annually, an estimated 20,000 to 25,000 people are diagnosed with non-melanoma skin cancer in Switzerland, and around 3,200 with melanoma. The good news is that skin cancer has high curability if detected early.

This is especially true for melanoma, where early diagnosis plays a crucial role in successful treatment. Non-melanoma skin cancers like squamous cell carcinoma (Spinalioma) and basal cell carcinoma (Basalioma) are also detected through skin cancer screening.

The examination is performed with a dermatoscope, a device used to closely examine skin areas for suspicious changes. If a suspicious change is found, a small tissue sample (biopsy) is taken and examined in a laboratory.

Breast Cancer Screening

Breast cancer is the most common cancer and leading cause of cancer death among women in Switzerland. More than 6,500 women are diagnosed with breast cancer annually, and over 1,300 die each year. However, the chances of curing breast cancer are good if it is detected early, as tumors are usually small, treatments less burdensome, and success rates significantly higher.

Therefore, it is important for women to regularly examine their breasts for changes and participate in recommended early detection screenings.

Breast cancer screening includes a clinical breast examination by a gynecologist and, from the age of 50, a mammography screening (every two years). This involves an X-ray of the breast to detect both benign and malignant changes in breast tissue.

Cervical Cancer Screening

Cervical cancer is most commonly diagnosed in women between 35 and 44 years. About 250 women are newly diagnosed with cervical cancer each year in Switzerland. Every three years, the costs for a Pap smear are covered. This test involves taking cells from the cervix with a swab, which are then examined for cell changes in a cytological analysis. This can detect and treat precancerous stages of cervical cancer early.

A test for human papillomavirus (HPV test), the cause of cervical cancer, is currently not covered by health insurance in Switzerland. Importantly, even those who have received an HPV vaccination should continue to undergo regular screenings since the vaccine does not protect against all cancer-causing HPV types.

Colorectal Cancer Screening

While colorectal cancer mostly affects people aged 50 and older, it can occur at any age.

Adults should start regular colorectal cancer screening at age 50. Those at higher risk due to family or personal history or other factors should consider starting earlier.

The colorectal cancer screening program includes a colonoscopy or a fecal occult blood test. Available fecal occult blood tests detect colorectal cancer in approximately 50-80% of cases. Colonoscopy detects around 89-95% of colorectal cancer cases. Several studies have shown that cancer mortality is 29-68% lower in people who undergo preventive colonoscopy compared to those who do not. Blood tests like liquid biopsy can also be a highly accurate indicator for colorectal cancer, with an accuracy of 83%.

Lung Cancer Screening

Approximately 4,900 people in Switzerland are diagnosed with lung cancer each year, and about 3,300 die from it. The best method to detect lung cancer early is a low-dose computed tomography (low-dose CT scan, LDCT). The accuracy of lung cancer screening with CT is 95%. However, lung cancer screening is not currently covered by health insurance.

Prostate Cancer Screening

Prostate cancer is the most common cancer among men in Switzerland, with around 6,600 new cases diagnosed annually. The risk with age, and most cases occur in men over 65. Therefore, annual to biennial prostate cancer screening is recommended for men aged 50 and older. Men with a family history of prostate cancer before the age of 65 should begin screening at 45.

Prostate cancer screening includes a digital rectal examination (DRE). However, small tumors or those not palpable due to their location may go undetected by DRE. Prostate-specific antigen (PSA) testing in the blood can detect prostate cancer. MRI scans of the prostate can identify even small tumors with 93% accuracy.

Does Health Insurance Cover Screening?

Health insurance in Switzerland covers the costs of various important preventive exams to promote the health of its insured members and detect diseases early.

• Gynecological preventive exam with Pap smear every three years
• Mammography for women at high risk of breast cancer
• Colorectal cancer screening: fecal occult blood test every two years and colonoscopy every 10 years for men and women aged 50 to 69

For more information on early detection programs available in your canton, visit Swiss Cancer Screening.

Conclusion

Screening programs are a crucial tool in the early detection of cancers. Early diagnosis can increase treatment success and reduce mortality rates. Individuals with risk factors should take advantage of regular preventive exams. However, screening is only covered by health insurance for certain types of cancer.

In addition to the mentioned preventive exams, blood analyses like liquid biopsy or radiological exams such as MRI can be considered supplementary diagnostic options. Depending on the type of cancer, liquid biopsy can be a promising option for detecting specific markers in the blood indicative of a tumor.

MRI can detect even the smallest tumors. Gain clarity with a full-body MRI scan at aeon.

Concentration difficulties, forgetfulness, fatigue, and lack of motivation: These symptoms can be signs of brain fog, a condition that can significantly impair cognitive performance.

Brain fog can lead to major limitations. Affected individuals are often unable to think clearly. In particular, brain fog is frequently mentioned as one of the many symptoms associated with long COVID.

In this article, we will take an in-depth look at the topic of brain fog, the associated symptoms and causes, as well as possible strategies to cope with brain fog.

What is Brain Fog?

"Brain fog" isn't a medical diagnosis, but a descriptive term for a cluster of cognitive symptoms. Individuals experiencing brain fog often report difficulty concentrating, memory lapses, persistent fatigue, and a general sense of mental cloudiness.

It's important to understand that brain fog is a symptom, not a disease itself, and typically arises as a consequence of underlying health conditions.

What are the Symptoms of Brain Fog?

The symptoms of Brain Fog syndrome include:

• Forgetting names or dates
• Difficulty finding words
• Concentration issues
• Lack of motivation
• Problems with multitasking

Brain Fog is typically temporary. This means that once the underlying cause or condition is treated, the symptom of Brain Fog usually subsides.

Brain Fog can affect many groups, including people with attention deficit hyperactivity disorder (ADHD), chronic pain, long COVID, sleep disorders, eating disorders, and other complex conditions. Depending on the cause, there are various ways to manage Brain Fog.

What Causes Brain Fog?

Brain fog, that frustrating feeling of mental fuzziness, remains a complex puzzle. While a single, definitive cause is elusive, emerging research points to several key factors.

Inflammation

One prominent theory centers on neuroinflammation. Brain cells communicate via intricate signaling networks. When inflammation disrupts these networks, it can impair cognitive function, leading to difficulty concentrating and processing information. Studies have shown that inflammation can damage nerve cells, hindering their ability to transmit signals effectively.

Microclots and Oxygen Deprivation

Recent investigations, particularly in long-COVID patients, suggest that microscopic blood clots might play a significant role. Brain examinations have revealed inflammation alongside fibrinogen deposits, a protein crucial for blood clotting. The hypothesis is that these microclots could impede oxygen delivery to the brain, contributing to brain fog symptoms.

It's important to recognize that brain fog can also stem from a variety of other factors, including:

Stress

When the body is under stress, it releases higher levels of stress hormones such as cortisol. Elevated cortisol levels can cause nerve cells in the hippocampus—the brain region responsible for memory and learning—to shrink, leading to cognitive impairment and difficulties in retaining new information.

Chronic stress not only leads to mental exhaustion and concentration problems but is also linked to an increased risk of depression. Additionally, cortisol promotes the production of free radicals, which can damage brain cells. Over time, this oxidative stress may contribute to neurodegenerative diseases such as Alzheimer's and dementia.

Lack of Sleep

Poor sleep quality is closely associated with cognitive decline and reduced mental performance. Sleep disorders are among the most common causes of chronic sleep deprivation, with conditions such as:

• Insomnia – Difficulty falling or staying asleep
• Narcolepsy – Excessive daytime sleepiness and sudden sleep attacks
• Restless Leg Syndrome (RLS) – Uncontrollable urge to move the legs, often accompanied by discomfort at night
• Sleep Apnea – Pauses in breathing during sleep, leading to poor oxygen supply and frequent awakenings

These disorders can result in chronic fatigue and sleep deprivation, both of which are linked to impaired brain function. Poor sleep affects memory consolidation, decision-making, and emotional regulation, increasing the risk of cognitive decline over time.

Hormonal Changes

Fluctuations in hormone levels can significantly impact cognitive function and contribute to brain fog. This is particularly evident during menstruation, pregnancy, and menopause, when hormonal shifts can lead to temporary cognitive impairments.

Studies suggest that some women experience difficulty concentrating after ovulation and in the days leading up to their period. Similarly, during pregnancy, levels of progesterone and estrogen rise rapidly to support fetal development, but these hormonal changes can also affect cognitive performance. Many pregnant and postpartum women report memory issues, often referred to as "pregnancy brain."

During menopause, the body undergoes a significant decline in estrogen production, which can impact brain function. Estrogen plays a crucial role in maintaining nerve cell integrity and regulating cerebral blood flow. A drop in estrogen levels can lead to reduced blood circulation in the brain, potentially affecting memory, concentration, and overall cognitive health.

Nutrition

In addition to hormonal imbalances, nutritional deficiencies can contribute to brain fog. The brain relies on a steady supply of essential vitamins and minerals to function optimally. A lack of these nutrients can lead to cognitive impairment, fatigue, and difficulty concentrating.

• Vitamin B12: Vitamin B12 is essential for nerve function, red blood cell production, and DNA synthesis. A deficiency can result in nerve damage, leading to memory problems and cognitive decline.
• Vitamin B1 (Thiamine): Thiamine plays a key role in energy production and neurotransmitter metabolism. A deficiency can reduce energy availability in the brain, impairing cognitive performance.
• Vitamin B6: Vitamin B6 is necessary for the production of neurotransmitters such as serotonin, dopamine, and GABA, which regulate mood and cognition. A deficiency can lead to imbalances in these neurotransmitters, affecting mental clarity.
• Vitamin B9 (Folic Acid): Folic acid supports DNA and RNA synthesis, crucial for brain cell repair and function. A deficiency may lead to cognitive decline and slower information processing.
• Vitamin D: Vitamin D regulates inflammation and supports neurotransmitter function. A deficiency has been linked to cognitive impairment, brain fog, and increased fatigue.
• Omega-3 Fatty Acids: Omega-3s are crucial for brain cell health and communication. These essential fatty acids help maintain cognitive function and protect against neurodegeneration.
• Iron: Iron is vital for oxygen transport to the brain. A deficiency can cause fatigue, brain fog, and reduced cognitive performance.
• Magnesium: Magnesium supports enzymatic reactions in the brain, protects the blood-brain barrier, and helps regulate neuronal activity. A deficiency can contribute to mental fatigue and difficulty concentrating.
• Vitamin C: Vitamin C is a powerful antioxidant that protects brain cells from oxidative stress and supports dopamine production, which is essential for focus and motivation.
• Choline: Choline is a key component of phospholipids, which make up brain cell membranes. It also has antioxidant properties that help protect against free radical damage, supporting memory and cognitive function.

Medications

Brain fog can not only result from stress, lack of sleep, hormonal imbalances, or nutritional deficiencies but also occur as a side effect of certain medications.

• Sedatives and painkillers: Some sleeping pills and painkillers can impair cognitive function, leading to brain fog, drowsiness, and slow thinking.
• Cancer treatments: Brain fog is also commonly reported after chemotherapy, a condition often referred to as "chemo brain." While the exact causes are not yet fully understood, it is believed to result from inflammation, oxidative stress, and changes in brain structure following cancer treatment.

Diseases

Various diseases that cause inflammation, fatigue, or fluctuations in blood sugar levels can contribute to mental fatigue and brain fog.

One example is chronic fatigue syndrome (CFS), a condition characterized by persistent and extreme exhaustion. Many CFS patients report difficulties with concentration, memory, and mental clarity.

The following conditions have also been linked to brain fog:

• Anemia – Reduced oxygen supply to the brain can lead to fatigue and cognitive impairment.
• Mental health disorders – Conditions such as depression and anxiety can affect focus, memory, and mental processing speed.
• Chronic pain – Disorders like fibromyalgia often involve widespread pain and cognitive dysfunction, sometimes referred to as "fibro fog."
• Diabetes – Fluctuating blood sugar levels can impair brain function and lead to fatigue, confusion, and difficulty concentrating.
• Migraines – Many migraine sufferers experience cognitive difficulties before, during, or after an attack.
• Hypothyroidism – An underactive thyroid slows metabolism, leading to fatigue, sluggish thinking, and memory issues.
• Dehydration – Even mild dehydration can reduce blood flow to the brain, impairing focus and cognitive function.
• Long COVID – Many individuals recovering from COVID-19 report lingering brain fog, which may result from inflammation, oxygen deprivation, or immune system overactivity.
• Sleep disorders – Conditions such as insomnia, sleep apnea, and restless leg syndrome can disrupt sleep quality, leading to daytime mental fatigue.
• Eating disorders – Malnutrition and nutrient deficiencies caused by conditions like anorexia or bulimia can negatively impact brain function.

In summary, brain fog is likely a multifaceted condition with potential causes ranging from neuroinflammation and microclots to hormonal changes and stress. Further research is crucial to fully understand its origins and develop effective solutions.

How to Deal with Brain Fog

If you experience Brain Fog, focus on a balanced diet, regular exercise, sufficient sleep, and stress reduction.

Proper Diet

Addressing potential nutrient deficiencies can sometimes help alleviate brain fog. Key nutrients for brain health include vitamin D, omega-3 fatty acids, magnesium, vitamin C, the B-vitamin complex, and zinc. However, research on the effectiveness of vitamin supplementation for brain fog remains inconclusive, as large-scale clinical trials are still lacking.

Hydration

Many people experience brain fog symptoms like fatigue, dizziness, and difficulty concentrating due to dehydration. Even a slight fluid loss of 2% can significantly impair cognitive function.

Since the brain is about 76% water, staying hydrated is crucial for optimal performance. Aim to drink at least 2.5 liters of water or unsweetened tea per day to keep your brain well-supplied with fluids.

Fasting

ntermittent fasting, which involves alternating periods of eating and fasting, has been linked to several cognitive benefits. The effects of intermittent fasting on brain function include:

• Improved Brain Plasticity: Fasting increases levels of BDNF (Brain-Derived Neurotrophic Factor), a protein that supports learning and memory.
• Reduced Inflammation: Fasting helps lower inflammation, which is associated with cognitive decline.
• Enhanced Energy Supply: Fasting improves mitochondrial efficiency, ensuring brain cells receive optimal energy.

To maximize benefits and minimize side effects, make sure to stay well-hydrated while fasting.

Stress Reduction

Chronic stress negatively impacts brain function in several ways:

• Memory Impairment: Long-term stress causes nerve cells in the hippocampus (the brain’s memory center) to shrink, leading to forgetfulness and learning difficulties.
• Increased Anxiety: Stress overstimulates the amygdala, the brain’s fear-processing center, making it harder to think rationally.
• Oxidative Damage: Stress triggers the release of cortisol, which promotes free radical formation, potentially damaging brain cells and increasing the risk of neurodegenerative diseases.

To counteract stress, try incorporating relaxation techniques such as meditation, yoga, or deep breathing into your daily routine.

Exercise

Physical activity is essential for maintaining cognitive function. Exercise improves blood circulation, ensuring that brain cells receive sufficient oxygen and nutrients to enhance concentration and mental clarity.

Additionally, exercise stimulates the growth of new nerve cells, which can improve memory and learning ability. Even small changes—such as taking a walk, stretching during work breaks, or trying new movements—can have a positive impact on brain health.

Conclusion

Brain fog refers to a state of impaired cognitive function, characterized by difficulty concentrating, forgetfulness, fatigue, and mental sluggishness.

Its causes are diverse, ranging from chronic stress, sleep deprivation, and hormonal imbalances to medical conditions such as long COVID, diabetes, and hypothyroidism. In addition to the core symptoms, brain fog can also manifest as trouble finding words, difficulties with multitasking, and slowed information processing.

The most effective way to combat brain fog is to address its root cause. Additionally, managing stress, maintaining a balanced diet, staying active, and prioritizing good sleep can help improve mental clarity and overall cognitive function.

If you're experiencing persistent brain fog, a full-body MRI scan can provide valuable insights into your overall health and help detect potential underlying conditions early. Take control of your well-being—schedule your MRI today and gain clarity about your health.

Prostate cancer is the most common cancer in men. In Switzerland, 30% of all cancer cases affect the prostate. Each year, about 7,400 Swiss men are newly diagnosed with prostate cancer. Almost all patients are over 50 years old at the time of diagnosis. The survival rate significantly depends on the tumor stage at the time of diagnosis. The 5-year survival rate is 95-99% at stage I and 34-50% at stage IV.

Prostate tumors are therefore common but rarely fatal. This is partly because they often grow slowly and are not very aggressive. In many cases, they cause no or barely noticeable symptoms, which is why they are often discovered by chance, if at all.

This means that there is a larger window of time in which prostate cancer can be treated and even cured.

This article gives you an overview of what prostate cancer is, how it develops, and how it can be treated. Additionally, you will learn about the preventive screenings available in Switzerland to detect prostate cancer as early as possible.

What is the Prostate?

The prostate is a gland located directly below the bladder, surrounding the upper part of the urethra. Its primary function is to produce part of the seminal fluid.

(Graphic showing the location of the prostate in the human body)

What is Prostate Cancer?

Prostate cancer, also known as prostate carcinoma, is a malignant disease of the prostate. It is the most common cancer in men. The two main risk factors for developing prostate cancer are increasing age and genetic predisposition.

A prostate carcinoma usually grows slowly and causes few symptoms. It is often discovered by chance or through targeted early detection screening. Therefore, regular screening is so important.

As long as the cancer remains within the prostate (localized), it is well-treatable and removable. However, if it has already spread to other organs or bones (metastasized), the chances of treatment decrease significantly.

What Causes Prostate Cancer?

The main causes of prostate carcinoma are age and family history (genetic factors). Hormonal factors, environmental influences, and diet are not yet sufficiently researched. Below, we briefly discuss the various causes.

Age

Age is the most significant risk factor for developing prostate carcinoma. Before the age of 40, the likelihood of developing prostate cancer is very rare. From the age of 50, the risk increases rapidly. About 60% of prostate carcinomas occur from the age of 65.

Family History

In up to 20% of cases, prostate carcinoma occurs more frequently within families. For example, if your father or brother has prostate cancer, your risk is about twice as high. If both father and brother are affected, your risk increases more than fivefold. Besides the number of direct relatives, their age also plays a role in risk calculation.

Other Factors

Several other factors are discussed as potential causes of the disease. However, in most cases, numerous studies with often different and contradictory results exist, making it impossible to make definitive statements.

Regarding environmental factors, it is noted that prostate cancer is less common in certain regions (including Asia). However, whether differences in genetic makeup, hormonal balance, or diet are responsible is not sufficiently researched. An indication that environmental factors may play a role is the fact that the risk of disease among Asians who migrate to the USA aligns with the risk of native US citizens in the next generation.

Obesity is also frequently discussed as a cause. Increased body weight correlates with an increased risk of developing an aggressive form of prostate carcinoma.

What Symptoms Can Indicate Prostate Cancer?

The challenge in early detection of prostate carcinoma is that it typically does not cause easily recognizable or cancer-specific early symptoms. Often, there are no symptoms at all until the cancer is far advanced. Therefore, early detection is so important.

Moreover, the symptoms that do appear usually affect the sexual organs and can have many other causes. For example, the prostate naturally enlarges with age (benign prostatic hyperplasia), which can compress the urethra and impair urine flow. Symptoms such as a weakened urine stream or frequent urination can also result from benign prostatic hyperplasia and are not necessarily signs of prostate cancer.

Nonetheless, you should have such symptoms clarified immediately, especially if several occur simultaneously. Below are the most common signs of possible prostate carcinoma:

• Problems with urination (weak urine stream, difficulty starting urination, inability to urinate)
• Increased frequency of urination
• Blood in the urine (hematuria)
• Erectile dysfunction
• Blood in the semen (hematospermia)
• Pain during ejaculation
• Pain in the lower back

How Can Prostate Cancer Be Prevented?

Since the primary causes of prostate carcinoma are advancing age and family history, regular screening is the most effective means of cancer prevention.

This screening can be done annually from the age of 50, or earlier if there is a family history. The costs for the first step of screening, the digital rectal examination, are covered by the Swiss Mandatory Health Insurance (OKP). This includes the deductible, but the annual franchise does not apply. For other or follow-up examinations, it depends on your insurance status whether you may have to cover part of the costs yourself.

Of course, the earlier the tumor is detected, the better the treatment options. In advanced prostate cancer (metastasized carcinomas), more intensive therapeutic measures may be necessary, and there is a higher risk that even these will not completely or permanently remove the cancer.

It is scientifically unproven but highly likely that a healthy lifestyle reduces both the risk of developing prostate carcinoma and the growth rate of existing tumors. This includes:

• Regular Exercise: At least three hours of moderate to intense training per week is recommended. This also helps avoid overweight, which is associated with more aggressive forms of prostate carcinoma.
• Red Fruits, Cruciferous Vegetables, and Soy Products: Several components of a plant-based diet are also associated with a protective effect against prostate cancer. These include lycopene (found in tomatoes and other red fruits), sulforaphane (found in cauliflower, Brussels sprouts, and broccoli), and isoflavones (found in soy).
• Limit Dairy Products: Moderate consumption of dairy products and calcium intake from plant-based foods may help reduce the risk of disease. Some studies show a possible link between high calcium and dairy product intake and an increased risk of prostate carcinoma, although other studies have not confirmed this.

How is Prostate Cancer Diagnosed?

Prostate carcinomas are most commonly found during screening examinations with your urologist. These check-ups typically consist of a digital rectal examination (DRE) and possibly an additional PSA (Prostate-Specific Antigen) test.

If there is suspicion after these initial examinations, your doctor will recommend a transrectal ultrasound (TRUS) or an MRI scan.

Therefore, MRI is a more direct and reliable method for diagnosing prostate cancer. Additionally, it can detect many other types of cancer and cover most generally recommended screenings (see article on screenings). As it is used significantly before the age of 50 – Dr. Felix Harder recommends regular MRI scans from about age 30 – MRI usually allows for earlier diagnosis of prostate cancer. This is invaluable for the success of cancer therapy.

The final and definitive diagnostic step is a prostate biopsy, where tissue samples are taken and analyzed in the lab.

Below, we provide a brief explanation of the individual diagnostic methods.

Digital Rectal Examination (DRE)

After a consultation, your urologist will ask you to lie on your side and relax. Then, they will insert a finger into your rectum to feel the prostate for enlargements, hardening, lumps, or other changes.

If there is an abnormal finding during palpation, your doctor will order further diagnostic methods.

PSA Test

In addition to the DRE, you can also have a Prostate-Specific Antigen (PSA) test. This involves analyzing your blood (after a simple blood draw) for a protein produced in the prostate and part of your seminal fluid.

An elevated PSA level may indicate the presence of prostate cancer. However, an elevated PSA level can also have other causes, such as prostate inflammation, cycling, or sexual activity. Therefore, the usefulness of the PSA test is quite controversial. Nevertheless, it remains an important tool for early detection of prostate cancer due to its simplicity. It should be used in combination with other diagnostic methods (e.g., MRI).

Transrectal Ultrasound (TRUS)

Transrectal ultrasound (TRUS) is an imaging method often used in addition to DRE. As the prostate is located between the bladder and pelvic floor in front of the rectum, it can be well reached by ultrasound.

Magnetic Resonance Imaging (MRI)

Unlike X-rays or CT scans, MRI is completely radiation-free. It also offers better soft tissue differentiation, making it ideal for visualizing internal organs, such as the prostate.

At aeon, we use modern scanners with a large bore diameter, so you don't feel confined. If you want to know how an MRI examination works with us, you can check it out step by step in this article (link to MRI article).

Prostate Biopsy

The definitive diagnosis of prostate carcinoma is made by prostate biopsy. There are various methods, but usually, a transrectal (via the rectum) prostate needle biopsy under ultrasound guidance is performed.

Systematic tissue samples are taken from the prostate according to a predetermined pattern. Additionally, samples are taken from areas previously diagnosed as abnormal by MRI, for example.

The prostate biopsy is usually performed on an outpatient basis with local anesthesia. As there is a risk of spreading germs from the rectum during the biopsy, you should take antibiotics to prevent infections.

How is Prostate Cancer Treated?

Prostate cancer can usually be treated well. Of course, the choice of method depends greatly on the patient, their history, the type of tumor, and the timing of the diagnosis.

In general, prostate tumors grow slowly compared to others, and long-term survival rates are high.

The most common treatment methods for prostate cancer are:

• Watchful Waiting / Active Surveillance
• Surgery (Radical Prostatectomy)
• Radiation Therapy
• Hormone Therapy
• Chemotherapy

Below, we briefly introduce the methods:

Watchful Waiting / Active Surveillance

Since prostate carcinomas often grow slowly and cause no or few symptoms, it may be advantageous for the patient to wait attentively rather than undergoing intensive therapy. The side effects of therapy could potentially harm the body more than benefit it.

Watchful waiting and active surveillance both aim to minimize the impact on the patient's quality of life while not missing the point when further therapy becomes necessary.

Radical Prostatectomy

In a radical prostatectomy, the prostate, the urethra within it, the seminal vesicles, and part of the vas deferens are removed. The surgical team may also remove lymph nodes. Radical prostatectomy is suitable for patients whose tumor is confined to the prostate.

Radiation Therapy

In prostate cancer, radiation therapy can be administered externally through the skin (percutaneous) or internally (brachytherapy, Greek: "brachy" = "short"). Radiation is focused on the affected areas of the prostate to target and kill the cancer cells. In brachytherapy, radioactive, rice-sized titanium seeds are implanted in the prostate to irradiate the tumor "from within."

Radiation therapy can be successful in the early stages of the disease but can also help alleviate symptoms in advanced cancer.

Hormone Therapy

Prostate carcinoma cells need male sex hormones (androgens), especially testosterone, to grow. Hormone therapy aims to deprive the tumor of androgens.

This slows the growth of cancer cells but also leads to physical reactions similar to those experienced by women during menopause: sweating, hot flashes, decreased libido, etc.

Hormone therapy is typically considered for men with advanced or metastatic prostate carcinoma.

Chemotherapy

If prostate carcinoma continues to grow despite hormone therapy and has already spread to other organs and bones, chemotherapy is usually used. The use of chemical agents, usually cytotoxins, aims to stop the growth of cancer cellsand ideally force their regression (remission) without harming healthy cells.

However, it is crucial to ensure that the side effects of the therapy do not outweigh the benefits. Therefore, all chemotherapy treatments are tailored to the individual patient, from the choice of agent to the dosage and duration of treatment to accompanying measures to alleviate side effects.

What is the Life Expectancy with Prostate Cancer?

The life expectancy for prostate cancer in the early stage is 95-99% even five years after diagnosis. In advanced stages, it drops to about 34-50% five years after diagnosis.

Overall, approximately 1,400 of those affected in Switzerland die annually from prostate cancer. This is mainly due to the often slow growth of this type of cancer.

The fact is that eight out of ten men diagnosed with prostate cancer die from another cause, highlighting the importance of weighing the treatment strategy.

Conclusion

Since prostate cancer usually causes few symptoms and grows slowly, it is often detected late or not at all.

Therefore, regular screenings are crucial. The earlier the diagnosis, the less likely prostate carcinoma will affect your life expectancy and quality of life. When found early, prostate carcinoma is very treatable.